NBAl的个人主页 - 老虎社区

NBAl

NBAl

暂无个人介绍

IP属地：未知

2关注

5粉丝

0主题

0勋章

2021-09-02

I scooped in few during the dip.

Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote>

2021-07-27

Will add more JD and NIO

Hot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中概股盘前恢复下行</blockquote>

2021-08-27

I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂

抱歉，原内容已删除

2021-08-02

Will enter when I have an opportunity. SEA is over valued at this time.

抱歉，原内容已删除

2021-08-09

Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features

抱歉，原内容已删除

2021-12-06

Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.

Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote>

2021-08-26

I was thinking of buying, now I will back off 😞

抱歉，原内容已删除

2021-07-26

Waiting for it to dip, I feel it is a value investmentas well

抱歉，原内容已删除

2021-07-30

Am a beginner, can I enter Amazon now.. guidance please

抱歉，原内容已删除

2021-11-15

Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582610336531043","uuid":"3582610336531043","gmtCreate":1619523668199,"gmtModify":1623066506738,"name":"NBAl","pinyin":"nbal","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":2,"tweetSize":54,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"80.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":698161349,"gmtCreate":1640319482440,"gmtModify":1640319814384,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Rivian has yet to prove and am&nbsp;not bullish on NIO yet as other Chinese EV’s are outperforming. Lucid (after it finds support)&nbsp;and Tesla (850 -880) range&nbsp;I will add them.","listText":"Rivian has yet to prove and am&nbsp;not bullish on NIO yet as other Chinese EV’s are outperforming. Lucid (after it finds support)&nbsp;and Tesla (850 -880) range&nbsp;I will add them.","text":"Rivian has yet to prove and am not bullish on NIO yet as other Chinese EV’s are outperforming. Lucid (after it finds support) and Tesla (850 -880) range I will add them.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698161349","repostId":"1128727196","repostType":2,"repost":{"id":"1128727196","kind":"news","pubTimestamp":1640305733,"share":"https://www.laohu8.com/m/news/1128727196?lang=zh_CN&edition=full","pubTime":"2021-12-24 08:28","market":"us","language":"en","title":"Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?<blockquote>Lucid、Rivian、蔚来和特斯拉是否会在2022年买入？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1128727196","media":"Motley Fool","summary":"These electric vehicle stocks are on sale, but that doesn't mean all are buys.","content":"<p><b>Key Points</b></p><p><blockquote><b>要点</b></blockquote></p><p> <ul>  <li>Lucid and Rivian are unproven but have a lot of potential.</li>  <li>Nio is down big from its high but just gave investors a jolt on Nio Day.</li>  <li>Tesla has a high valuation but is in its best shape ever.</li> </ul> December has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many&nbsp;growth stocks&nbsp;are actually down a lot for the year, and&nbsp;some are close to their 52-week lows.</p><p><blockquote><ul><li>Lucid和Rivian尚未得到证实，但潜力很大。</li><li>蔚来股价较高点大幅下跌，但刚刚在蔚来国庆日给投资者带来了震动。</li><li>特斯拉估值很高，但正处于有史以来最好的状态。</li></ul>到目前为止，12月是一个疯狂的月份，因为主要股指每天都会出现大幅波动。虽然一些股票徘徊在历史高点附近，但许多成长型股票今年实际上下跌了很多，有些股票接近52周低点。</blockquote></p><p> <b>Lucid Group</b>(NASDAQ:LCID),<b>Rivian Automotive</b>(NASDAQ:RIVN),<b>Nio</b>(NYSE:NIO), and&nbsp;<b>Tesla</b>(NASDAQ:TSLA)&nbsp;are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.</p><p><blockquote><b>Lucid集团</b>（纳斯达克：LCID），<b>Rivian汽车</b>（纳斯达克：RIVN），<b>蔚来</b>（纽约证券交易所代码：蔚来），以及<b>特斯拉</b>（纳斯达克：TSLA）是四只备受瞩目的电动汽车（EV）股票，均较高点下跌25%或更多。以下是每一款的内幕，以及现在最值得购买的一款。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a625e7f56da175a14e5d6cbfcdce47c\" tg-width=\"2000\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: NIO.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：蔚来。</span></p></blockquote></p><p> <b>Lucid has some serious upside</b></p><p><blockquote><b>Lucid有一些严重的优势</b></blockquote></p><p> Share prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid&nbsp;delivered on its promises in 2021&nbsp;by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet&nbsp;recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents&nbsp;that was issued on Dec. 3&nbsp;and a controversial senior note offering, have taken a toll on Lucid stock of late.</p><p><blockquote>Lucid Group的股价较高点下跌了38%，这家崭露头角的电动轿车公司将面临充满挑战的2022年。Lucid在2021年兑现了其承诺，扩大了制造工厂、上市并筹集现金、进入大规模生产并开始向客户交付。然而，最近发生的事件，尤其是美国证券交易委员会(SEC)于12月3日发布的文件要求以及有争议的优先票据发行，最近对Lucid股票造成了损害。</blockquote></p><p> Despite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently&nbsp;sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a&nbsp;staple in the luxury sedan market&nbsp;over time.</p><p><blockquote>尽管有负面报道，但有理由相信Lucid可能是一只值得长期持有的优秀股票。对于Lucid来说，优先票据发行的时机非常好，该公司的股票估值为每股54.78美元（比撰写本文时的股价溢价37%）。它还为公司提供了加速生产、扩大制造能力和满足目前超过17,000份预订的客户需求所需的现金。鉴于其令人难以置信的电池技术，随着时间的推移，Lucid可能会成为豪华轿车市场的主要产品。</blockquote></p><p> <b>Rivian isn't worth $86 billion...yet</b></p><p><blockquote><b>Rivian的身价还不到860亿美元</b></blockquote></p><p> Rivian has seen its stock sink as the&nbsp;honeymoon period after its initial public offering&nbsp;(IPO) draws to a close. In fact, Rivian's share price&nbsp;fell over 10%&nbsp;on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.</p><p><blockquote>随着首次公开募股（IPO）结束后的蜜月期，Rivian股价下跌。事实上，在Rivian公布2021年第三季度财报后，该公司股价在12月17日下跌了10%以上，这是其作为上市公司的首次报告。低于预期的客户交付量、超出预期的损失，以及需要大量资金才能将其制造和充电网络扩大到Rivian希望的规模的严酷现实，这些因素加在一起，导致整个季度令人失望。然而，Rivian的预订数量正在以极快的速度增长——事实上，比Lucid快得多。然而，在Rivian能够设定目标然后达到或超过这些目标之前，很难相信该公司的发展轨迹，更不用说将Rivian估值为860亿美元了。</blockquote></p><p> <b>Down but not out</b></p><p><blockquote><b>落魄但不出局</b></blockquote></p><p> No stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.</p><p><blockquote>这份名单上没有一只股票比中国汽车制造商蔚来更偏离高点，该公司股价下跌55%，目前徘徊在52周低点附近。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3055b147aea5ec316e8f30352bbd489d\" tg-width=\"720\" tg-height=\"516\" width=\"100%\" height=\"auto\"><span>LCID DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的LCID数据</span></p></blockquote></p><p> It wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.</p><p><blockquote>不久前，蔚来也受到了Lucid和Rivian在过去几个月中受到的同样的关注。但最近，它发现自己置身于聚光灯之外，或者因为负面原因短暂地出现在聚光灯下。</blockquote></p><p> Nio has been mass-producing&nbsp;electric cars&nbsp;for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an&nbsp;uncertain growth plan in Europe&nbsp;are all headwinds facing Nio right now. What's more, the SEC is&nbsp;tightening its grip&nbsp;on foreign companies like Nio.</p><p><blockquote>蔚来已经大规模生产电动汽车几年了，正在成为该领域的老牌参与者。产量数据不一致以及欧洲增长计划的不确定都是蔚来目前面临的阻力。此外，美国证券交易委员会正在加强对蔚来等外国公司的控制。</blockquote></p><p> However, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.</p><p><blockquote>然而，蔚来在12月18日举办了备受期待的蔚来日，推出了新款ET5中型轿车并发布了各种公告。蔚来并不缺乏创新，可能会成为巨大的长期赢家。</blockquote></p><p> <b>Firing on all electric motors</b></p><p><blockquote><b>在所有电动机上点火</b></blockquote></p><p> Tesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.</p><p><blockquote>由于投资者努力应对许多成长型股票的估值担忧，特斯拉股价较高点“仅”下跌25%。特斯拉不再是以前那个无利可图、五花八门的公司，但它的定价非常完美，市销率为22.5，市盈率为301.8。</blockquote></p><p> Despite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are&nbsp;reasons to like the company for years to come.</p><p><blockquote>尽管估值极高，但特斯拉公司还是有很多值得喜欢的地方。其行业领先的营业利润率、令人印象深刻的增长、多元化的业务以及在不断增长的电动汽车行业中的市场领先地位是未来几年看好该公司的原因。</blockquote></p><p> <b>An EV basket for 2022</b></p><p><blockquote><b>2022年电动汽车篮子</b></blockquote></p><p></p><p> Two ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a&nbsp;50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.</p><p><blockquote>应对顶级电动汽车股票抛售的两种方法是篮子策略和观望策略。比方说，投资Lucid和特斯拉50/50的股份，甚至投资名单上所有四家公司的股份，可以接触到市场的多个方面，同时限制任何一家公司可能对您的投资组合造成的损害。</blockquote></p><p> However, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.</p><p><blockquote>然而，我们很可能还需要数年时间才能实现Lucid、Rivian或蔚来的持续盈利。对于许多投资者来说，简单地等待电动汽车领域成熟然后挑选赢家可能会留下一些钱，但这可能是一个更安全且仍然有回报的赌注。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?<blockquote>Lucid、Rivian、蔚来和特斯拉是否会在2022年买入？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?<blockquote>Lucid、Rivian、蔚来和特斯拉是否会在2022年买入？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-24 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Key Points</b></p><p><blockquote><b>要点</b></blockquote></p><p> <ul>  <li>Lucid and Rivian are unproven but have a lot of potential.</li>  <li>Nio is down big from its high but just gave investors a jolt on Nio Day.</li>  <li>Tesla has a high valuation but is in its best shape ever.</li> </ul> December has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many&nbsp;growth stocks&nbsp;are actually down a lot for the year, and&nbsp;some are close to their 52-week lows.</p><p><blockquote><ul><li>Lucid和Rivian尚未得到证实，但潜力很大。</li><li>蔚来股价较高点大幅下跌，但刚刚在蔚来国庆日给投资者带来了震动。</li><li>特斯拉估值很高，但正处于有史以来最好的状态。</li></ul>到目前为止，12月是一个疯狂的月份，因为主要股指每天都会出现大幅波动。虽然一些股票徘徊在历史高点附近，但许多成长型股票今年实际上下跌了很多，有些股票接近52周低点。</blockquote></p><p> <b>Lucid Group</b>(NASDAQ:LCID),<b>Rivian Automotive</b>(NASDAQ:RIVN),<b>Nio</b>(NYSE:NIO), and&nbsp;<b>Tesla</b>(NASDAQ:TSLA)&nbsp;are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.</p><p><blockquote><b>Lucid集团</b>（纳斯达克：LCID），<b>Rivian汽车</b>（纳斯达克：RIVN），<b>蔚来</b>（纽约证券交易所代码：蔚来），以及<b>特斯拉</b>（纳斯达克：TSLA）是四只备受瞩目的电动汽车（EV）股票，均较高点下跌25%或更多。以下是每一款的内幕，以及现在最值得购买的一款。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a625e7f56da175a14e5d6cbfcdce47c\" tg-width=\"2000\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: NIO.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：蔚来。</span></p></blockquote></p><p> <b>Lucid has some serious upside</b></p><p><blockquote><b>Lucid有一些严重的优势</b></blockquote></p><p> Share prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid&nbsp;delivered on its promises in 2021&nbsp;by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet&nbsp;recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents&nbsp;that was issued on Dec. 3&nbsp;and a controversial senior note offering, have taken a toll on Lucid stock of late.</p><p><blockquote>Lucid Group的股价较高点下跌了38%，这家崭露头角的电动轿车公司将面临充满挑战的2022年。Lucid在2021年兑现了其承诺，扩大了制造工厂、上市并筹集现金、进入大规模生产并开始向客户交付。然而，最近发生的事件，尤其是美国证券交易委员会(SEC)于12月3日发布的文件要求以及有争议的优先票据发行，最近对Lucid股票造成了损害。</blockquote></p><p> Despite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently&nbsp;sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a&nbsp;staple in the luxury sedan market&nbsp;over time.</p><p><blockquote>尽管有负面报道，但有理由相信Lucid可能是一只值得长期持有的优秀股票。对于Lucid来说，优先票据发行的时机非常好，该公司的股票估值为每股54.78美元（比撰写本文时的股价溢价37%）。它还为公司提供了加速生产、扩大制造能力和满足目前超过17,000份预订的客户需求所需的现金。鉴于其令人难以置信的电池技术，随着时间的推移，Lucid可能会成为豪华轿车市场的主要产品。</blockquote></p><p> <b>Rivian isn't worth $86 billion...yet</b></p><p><blockquote><b>Rivian的身价还不到860亿美元</b></blockquote></p><p> Rivian has seen its stock sink as the&nbsp;honeymoon period after its initial public offering&nbsp;(IPO) draws to a close. In fact, Rivian's share price&nbsp;fell over 10%&nbsp;on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.</p><p><blockquote>随着首次公开募股（IPO）结束后的蜜月期，Rivian股价下跌。事实上，在Rivian公布2021年第三季度财报后，该公司股价在12月17日下跌了10%以上，这是其作为上市公司的首次报告。低于预期的客户交付量、超出预期的损失，以及需要大量资金才能将其制造和充电网络扩大到Rivian希望的规模的严酷现实，这些因素加在一起，导致整个季度令人失望。然而，Rivian的预订数量正在以极快的速度增长——事实上，比Lucid快得多。然而，在Rivian能够设定目标然后达到或超过这些目标之前，很难相信该公司的发展轨迹，更不用说将Rivian估值为860亿美元了。</blockquote></p><p> <b>Down but not out</b></p><p><blockquote><b>落魄但不出局</b></blockquote></p><p> No stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.</p><p><blockquote>这份名单上没有一只股票比中国汽车制造商蔚来更偏离高点，该公司股价下跌55%，目前徘徊在52周低点附近。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3055b147aea5ec316e8f30352bbd489d\" tg-width=\"720\" tg-height=\"516\" width=\"100%\" height=\"auto\"><span>LCID DATA BY YCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>YCHARTS提供的LCID数据</span></p></blockquote></p><p> It wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.</p><p><blockquote>不久前，蔚来也受到了Lucid和Rivian在过去几个月中受到的同样的关注。但最近，它发现自己置身于聚光灯之外，或者因为负面原因短暂地出现在聚光灯下。</blockquote></p><p> Nio has been mass-producing&nbsp;electric cars&nbsp;for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an&nbsp;uncertain growth plan in Europe&nbsp;are all headwinds facing Nio right now. What's more, the SEC is&nbsp;tightening its grip&nbsp;on foreign companies like Nio.</p><p><blockquote>蔚来已经大规模生产电动汽车几年了，正在成为该领域的老牌参与者。产量数据不一致以及欧洲增长计划的不确定都是蔚来目前面临的阻力。此外，美国证券交易委员会正在加强对蔚来等外国公司的控制。</blockquote></p><p> However, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.</p><p><blockquote>然而，蔚来在12月18日举办了备受期待的蔚来日，推出了新款ET5中型轿车并发布了各种公告。蔚来并不缺乏创新，可能会成为巨大的长期赢家。</blockquote></p><p> <b>Firing on all electric motors</b></p><p><blockquote><b>在所有电动机上点火</b></blockquote></p><p> Tesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.</p><p><blockquote>由于投资者努力应对许多成长型股票的估值担忧，特斯拉股价较高点“仅”下跌25%。特斯拉不再是以前那个无利可图、五花八门的公司，但它的定价非常完美，市销率为22.5，市盈率为301.8。</blockquote></p><p> Despite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are&nbsp;reasons to like the company for years to come.</p><p><blockquote>尽管估值极高，但特斯拉公司还是有很多值得喜欢的地方。其行业领先的营业利润率、令人印象深刻的增长、多元化的业务以及在不断增长的电动汽车行业中的市场领先地位是未来几年看好该公司的原因。</blockquote></p><p> <b>An EV basket for 2022</b></p><p><blockquote><b>2022年电动汽车篮子</b></blockquote></p><p></p><p> Two ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a&nbsp;50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.</p><p><blockquote>应对顶级电动汽车股票抛售的两种方法是篮子策略和观望策略。比方说，投资Lucid和特斯拉50/50的股份，甚至投资名单上所有四家公司的股份，可以接触到市场的多个方面，同时限制任何一家公司可能对您的投资组合造成的损害。</blockquote></p><p> However, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.</p><p><blockquote>然而，我们很可能还需要数年时间才能实现Lucid、Rivian或蔚来的持续盈利。对于许多投资者来说，简单地等待电动汽车领域成熟然后挑选赢家可能会留下一些钱，但这可能是一个更安全且仍然有回报的赌注。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","NIO":"蔚来","TSLA":"特斯拉","LCID":"Lucid Group Inc"},"source_url":"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128727196","content_text":"Key Points\n\nLucid and Rivian are unproven but have a lot of potential.\nNio is down big from its high but just gave investors a jolt on Nio Day.\nTesla has a high valuation but is in its best shape ever.\n\nDecember has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many growth stocks are actually down a lot for the year, and some are close to their 52-week lows.\nLucid Group(NASDAQ:LCID),Rivian Automotive(NASDAQ:RIVN),Nio(NYSE:NIO), and Tesla(NASDAQ:TSLA) are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.\nIMAGE SOURCE: NIO.\nLucid has some serious upside\nShare prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid delivered on its promises in 2021 by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents that was issued on Dec. 3 and a controversial senior note offering, have taken a toll on Lucid stock of late.\nDespite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a staple in the luxury sedan market over time.\nRivian isn't worth $86 billion...yet\nRivian has seen its stock sink as the honeymoon period after its initial public offering (IPO) draws to a close. In fact, Rivian's share price fell over 10% on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.\nDown but not out\nNo stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.\nLCID DATA BY YCHARTS\nIt wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.\nNio has been mass-producing electric cars for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an uncertain growth plan in Europe are all headwinds facing Nio right now. What's more, the SEC is tightening its grip on foreign companies like Nio.\nHowever, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.\nFiring on all electric motors\nTesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.\nDespite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are reasons to like the company for years to come.\nAn EV basket for 2022\nTwo ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a 50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.\nHowever, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.","news_type":1,"symbols_score_info":{"RIVN":0.9,"LCID":0.9,"NIO":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4284,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3583106134648492","idStr":"3583106134648492"},"content":"ford $Tesla Motors(TSLA)$ barring black swan event for short term unlikely to go below 900. Elon is almost done selling. less opportunity for shorts.","text":"ford $Tesla Motors(TSLA)$ barring black swan event for short term unlikely to go below 900. Elon is almost done selling. less opportunity for shorts.","html":"ford $Tesla Motors(TSLA)$ barring black swan event for short term unlikely to go below 900. Elon is almost done selling. less opportunity for shorts."}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693822211,"gmtCreate":1640004466150,"gmtModify":1640004466273,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Invest money that we wouldn’t need for next 3years atleast.","listText":"Invest money that we wouldn’t need for next 3years atleast.","text":"Invest money that we wouldn’t need for next 3years atleast.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693822211","repostId":"1160299527","repostType":4,"isVote":1,"tweetType":1,"viewCount":3923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693901232,"gmtCreate":1639956847455,"gmtModify":1639956847539,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Wow, if she was so convinced about the strategyshe wouldn’t have use pump and dump.. it is like catching a falling knife and hope the wounds will heal one day.","listText":"Wow, if she was so convinced about the strategyshe wouldn’t have use pump and dump.. it is like catching a falling knife and hope the wounds will heal one day.","text":"Wow, if she was so convinced about the strategyshe wouldn’t have use pump and dump.. it is like catching a falling knife and hope the wounds will heal one day.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693901232","repostId":"2192708619","repostType":4,"repost":{"id":"2192708619","kind":"highlight","pubTimestamp":1639954209,"share":"https://www.laohu8.com/m/news/2192708619?lang=zh_CN&edition=full","pubTime":"2021-12-20 06:50","market":"us","language":"en","title":"Cathie Wood says stocks have corrected into 'deep value territory' and won't let benchmarks 'hold our strategies hostage'<blockquote>凯西·伍德表示，股市已修正至“深度价值区域”，不会让基准“挟持我们的策略”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2192708619","media":"MarketWatch","summary":"ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovat","content":"<p>ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovation strategies that had made her suite of exchange-traded funds among the most popular, and best-performing, on Wall Street in 2020.</p><p><blockquote>ARK Invest创始人凯西·伍德(Cathie Wood)为曾经雄心勃勃的颠覆性创新战略进行了最新辩护，这些战略使她的交易所交易基金套件成为2020年华尔街最受欢迎、表现最好的基金之一。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5e17c2568a6dc81e7e3573ede78dcfb0\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Patrick T. Fallon/AFP/Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>帕特里克·T·法伦/法新社/盖蒂图片社</span></p></blockquote></p><p> In a Friday evening blog post, Wood said that despite a brutal stretch that has compelled the operators of the ARK Invest ETFs, including the flagship Ark Innovation&nbsp;fund, to do some soul-searching, the fund manager is sticking to her game plan.</p><p><blockquote>伍德在周五晚上的一篇博客文章中表示，尽管经历了残酷的考验，迫使包括旗舰方舟创新基金在内的方舟投资ETF的运营商进行了一些自我反省，但这位基金经理仍坚持她的游戏计划。</blockquote></p><p>   “‘With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years.’”  “We won’t let benchmarks and tracking errors hold our strategies hostage to the existing world order,” Wood wrote. She described the success of the ARK ETFs as one not solely bolstered by fervor for “stay at home” investment opportunities, amid the COVID pandemic, but rooted in identifying paradigm-shifting innovation, from blockchain and bitcoin&nbsp;to electric vehicles.</p><p><blockquote>“‘在五年的投资时间范围内，我们对这些平台的预测表明，我们今天的策略可以在未来五年内实现30-40%的复合年回报率。’”“我们不会让基准和跟踪错误使我们的战略受制于现有的世界秩序，”伍德写道。她将ARK ETF的成功描述为，不仅得益于在新冠疫情期间对“呆在家里”投资机会的热情，而且植根于识别从区块链和比特币到电动汽车的范式转变创新。</blockquote></p><p> “Critical to investment success will be moving to the right side of change, avoiding industries and companies caught in the crosshairs of ‘creative destruction’ and embracing those on the leading edge of ‘disruptive innovation,'” Wood wrote.</p><p><blockquote>伍德写道：“投资成功的关键是转向变革的正确方向，避免陷入‘创造性破坏’的行业和公司，并拥抱那些处于‘颠覆性创新’前沿的行业和公司。”</blockquote></p><p> On Friday, ARK Innovation ended the session up nearly 6% and produced its second straight sharp weekly gain, up 1.1%, following a 1.8% advance in the prior week. The advance for ARK Innovation still leaves the actively managed fund down nearly 22% in the year to date, as the broader S&amp;P 500,the Dow Jones Industrial Average&nbsp;and the technology Nasdaq Composite Index&nbsp;have faced whipsawing volatility derived primarily from concerns about more transmissible strains of COVID, surging inflation and global monetary policy’s reaction to those pricing pressures. Year-to-date the S&amp;P 500 index is up 864.57 points or 23.02%.</p><p><blockquote>周五，ARK Innovation收盘上涨近6%，连续第二周大幅上涨，上涨1.1%，此前一周上涨1.8%。ARK Innovation的上涨仍然导致该主动管理型基金今年迄今下跌了近22%，因为更广泛的标普500、道琼斯工业平均指数和科技纳斯达克综合指数面临剧烈波动，这主要是由于对传染性更强的担忧新冠疫情、通胀飙升以及全球货币政策对这些定价压力的反应。年初至今，标普500指数上涨864.57点，涨幅23.02%。</blockquote></p><p> ARK’s seven ETFs returned an average of 141% in 2020, on the back of gains from companies such as&nbsp;<b>Tesla Inc.</b>,and&nbsp;<b>Teladoc Health Inc</b>.,&nbsp;making Wood the toast of Wall Street. But those funds, focused primarily on companies that aren’t yet profitable, have been limping lower since hitting a peak back in February, and their woeful performance has raised questions about the prospects for the ETFs in the months and years to come.</p><p><blockquote>ARK旗下7只ETF 2020年平均回报率为141%，得益于以下公司的收益<b>特斯拉公司。</b>，和<b>Teladoc健康公司</b>.，让伍德成为华尔街的宠儿。但这些基金主要专注于尚未盈利的公司，自2月份达到峰值以来一直在走低，其糟糕的表现引发了人们对ETF未来几个月和几年前景的质疑。</blockquote></p><p> Wood urged investors to maintain their support of the ARK complex and said that maintaining a long-term, five-year time horizon would be the best way to judge the fund manager’s true performance.</p><p><blockquote>伍德敦促投资者保持对方舟综合体的支持，并表示保持长期的五年时间范围将是判断基金经理真实业绩的最佳方式。</blockquote></p><p> “With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years,” the ARK CEO wrote.</p><p><blockquote>ARK首席执行官写道：“以五年的投资时间范围，我们对这些平台的预测表明，我们今天的策略可以在未来五年内实现30-40%的复合年回报率。”</blockquote></p><p> “In other words, if our research is correct—and I believe that our research on innovation is the best in the financial world—then our strategies will triple to quintuple in value over the next five years,”&nbsp;Wood added.</p><p><blockquote>“换句话说，如果我们的研究是正确的——我相信我们对创新的研究是金融界最好的——那么我们的战略价值将在未来五年内增加三到五倍，”伍德补充道。</blockquote></p><p> The ARK founder also made the case that the Nasdaq and S&amp;P 500 could be the bigger disappointment to return-eager investors in the longer-term because they are more overvalued than the disruptive investments that comprise her funds.</p><p><blockquote>这位方舟创始人还表示，从长远来看，纳斯达克和标普500可能会让渴望回报的投资者更失望，因为它们的估值比构成她基金的颠覆性投资更高估。</blockquote></p><p> “Unlike many innovation-related stocks, equity benchmarks are selling at record high prices and near record high valuations, 26x for the S&amp;P 500 and 127x for the Nasdaq on a trailing twelve-month basis,” Wood wrote.</p><p><blockquote>伍德写道：“与许多与创新相关的股票不同，股票基准正以创纪录的高价和接近创纪录的高估值出售，过去12个月标普500为26倍，纳斯达克为127倍。”</blockquote></p><p> She said that the “five major innovation platforms which involve 14 technologies are likely to transform the existing world order and that so-called tried and true investment strategies “will disappoint during the next five to ten years as DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology scale and converge.”</p><p><blockquote>她表示，“涉及14项技术的五大创新平台可能会改变现有的世界秩序，随着DNA测序、机器人、能源存储、人工智能和区块链技术的规模和融合，所谓的屡试不爽的投资策略”将在未来五到十年内令人失望。”</blockquote></p><p> Wood also made the case that the so-called wall of worry, with inflation fears representing perhaps the biggest concern, provided an ideal backdrop for further advances in innovation stocks in the longer run because the dot-com markets of the late-1990s weren’t properly buffeted by investor concerns. The thinking is that “walls of worry” tend to limit market euphoria.</p><p><blockquote>伍德还指出，所谓的担忧墙（其中通胀担忧可能是最大的担忧）从长远来看为创新股的进一步上涨提供了理想的背景，因为20世纪90年代末的互联网市场并没有受到投资者担忧的适当打击。人们的想法是，“担忧之墙”往往会限制市场的兴奋。</blockquote></p><p> “In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space,” she wrote. “No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights,” Wood said.</p><p><blockquote>她写道：“我们认为，建立在高市盈率股票基础上的担忧之墙对创新领域的股票来说是个好兆头。”伍德表示：“1999年，股市并不存在担忧之墙，也没有受到考验。这一次，担忧之墙已经达到了巨大的高度。”</blockquote></p><p> On the macroeconomic front, Wood said that deflation, rather than inflation, could be a bigger problem for markets in the coming months.</p><p><blockquote>在宏观经济方面，伍德表示，通货紧缩而不是通胀可能是未来几个月市场面临的更大问题。</blockquote></p><p></p><p> “That said, my conviction is growing that the bigger surprise to the markets will be price deflation – both cyclical and secular – and that, after collapsing this year, higher multiple stocks could turn around dramatically during the next year,” she wrote.</p><p><blockquote>她写道：“也就是说，我越来越相信，市场面临的更大惊喜将是价格通货紧缩——无论是周期性的还是长期的——而且在今年崩溃之后，市盈率较高的股票可能会在明年大幅逆转。”</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood says stocks have corrected into 'deep value territory' and won't let benchmarks 'hold our strategies hostage'<blockquote>凯西·伍德表示，股市已修正至“深度价值区域”，不会让基准“挟持我们的策略”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood says stocks have corrected into 'deep value territory' and won't let benchmarks 'hold our strategies hostage'<blockquote>凯西·伍德表示，股市已修正至“深度价值区域”，不会让基准“挟持我们的策略”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-12-20 06:50</span>\n</p>\n</h4>\n</header>\n<article>\n<p>ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovation strategies that had made her suite of exchange-traded funds among the most popular, and best-performing, on Wall Street in 2020.</p><p><blockquote>ARK Invest创始人凯西·伍德(Cathie Wood)为曾经雄心勃勃的颠覆性创新战略进行了最新辩护，这些战略使她的交易所交易基金套件成为2020年华尔街最受欢迎、表现最好的基金之一。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5e17c2568a6dc81e7e3573ede78dcfb0\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Patrick T. Fallon/AFP/Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>帕特里克·T·法伦/法新社/盖蒂图片社</span></p></blockquote></p><p> In a Friday evening blog post, Wood said that despite a brutal stretch that has compelled the operators of the ARK Invest ETFs, including the flagship Ark Innovation&nbsp;fund, to do some soul-searching, the fund manager is sticking to her game plan.</p><p><blockquote>伍德在周五晚上的一篇博客文章中表示，尽管经历了残酷的考验，迫使包括旗舰方舟创新基金在内的方舟投资ETF的运营商进行了一些自我反省，但这位基金经理仍坚持她的游戏计划。</blockquote></p><p>   “‘With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years.’”  “We won’t let benchmarks and tracking errors hold our strategies hostage to the existing world order,” Wood wrote. She described the success of the ARK ETFs as one not solely bolstered by fervor for “stay at home” investment opportunities, amid the COVID pandemic, but rooted in identifying paradigm-shifting innovation, from blockchain and bitcoin&nbsp;to electric vehicles.</p><p><blockquote>“‘在五年的投资时间范围内，我们对这些平台的预测表明，我们今天的策略可以在未来五年内实现30-40%的复合年回报率。’”“我们不会让基准和跟踪错误使我们的战略受制于现有的世界秩序，”伍德写道。她将ARK ETF的成功描述为，不仅得益于在新冠疫情期间对“呆在家里”投资机会的热情，而且植根于识别从区块链和比特币到电动汽车的范式转变创新。</blockquote></p><p> “Critical to investment success will be moving to the right side of change, avoiding industries and companies caught in the crosshairs of ‘creative destruction’ and embracing those on the leading edge of ‘disruptive innovation,'” Wood wrote.</p><p><blockquote>伍德写道：“投资成功的关键是转向变革的正确方向，避免陷入‘创造性破坏’的行业和公司，并拥抱那些处于‘颠覆性创新’前沿的行业和公司。”</blockquote></p><p> On Friday, ARK Innovation ended the session up nearly 6% and produced its second straight sharp weekly gain, up 1.1%, following a 1.8% advance in the prior week. The advance for ARK Innovation still leaves the actively managed fund down nearly 22% in the year to date, as the broader S&amp;P 500,the Dow Jones Industrial Average&nbsp;and the technology Nasdaq Composite Index&nbsp;have faced whipsawing volatility derived primarily from concerns about more transmissible strains of COVID, surging inflation and global monetary policy’s reaction to those pricing pressures. Year-to-date the S&amp;P 500 index is up 864.57 points or 23.02%.</p><p><blockquote>周五，ARK Innovation收盘上涨近6%，连续第二周大幅上涨，上涨1.1%，此前一周上涨1.8%。ARK Innovation的上涨仍然导致该主动管理型基金今年迄今下跌了近22%，因为更广泛的标普500、道琼斯工业平均指数和科技纳斯达克综合指数面临剧烈波动，这主要是由于对传染性更强的担忧新冠疫情、通胀飙升以及全球货币政策对这些定价压力的反应。年初至今，标普500指数上涨864.57点，涨幅23.02%。</blockquote></p><p> ARK’s seven ETFs returned an average of 141% in 2020, on the back of gains from companies such as&nbsp;<b>Tesla Inc.</b>,and&nbsp;<b>Teladoc Health Inc</b>.,&nbsp;making Wood the toast of Wall Street. But those funds, focused primarily on companies that aren’t yet profitable, have been limping lower since hitting a peak back in February, and their woeful performance has raised questions about the prospects for the ETFs in the months and years to come.</p><p><blockquote>ARK旗下7只ETF 2020年平均回报率为141%，得益于以下公司的收益<b>特斯拉公司。</b>，和<b>Teladoc健康公司</b>.，让伍德成为华尔街的宠儿。但这些基金主要专注于尚未盈利的公司，自2月份达到峰值以来一直在走低，其糟糕的表现引发了人们对ETF未来几个月和几年前景的质疑。</blockquote></p><p> Wood urged investors to maintain their support of the ARK complex and said that maintaining a long-term, five-year time horizon would be the best way to judge the fund manager’s true performance.</p><p><blockquote>伍德敦促投资者保持对方舟综合体的支持，并表示保持长期的五年时间范围将是判断基金经理真实业绩的最佳方式。</blockquote></p><p> “With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years,” the ARK CEO wrote.</p><p><blockquote>ARK首席执行官写道：“以五年的投资时间范围，我们对这些平台的预测表明，我们今天的策略可以在未来五年内实现30-40%的复合年回报率。”</blockquote></p><p> “In other words, if our research is correct—and I believe that our research on innovation is the best in the financial world—then our strategies will triple to quintuple in value over the next five years,”&nbsp;Wood added.</p><p><blockquote>“换句话说，如果我们的研究是正确的——我相信我们对创新的研究是金融界最好的——那么我们的战略价值将在未来五年内增加三到五倍，”伍德补充道。</blockquote></p><p> The ARK founder also made the case that the Nasdaq and S&amp;P 500 could be the bigger disappointment to return-eager investors in the longer-term because they are more overvalued than the disruptive investments that comprise her funds.</p><p><blockquote>这位方舟创始人还表示，从长远来看，纳斯达克和标普500可能会让渴望回报的投资者更失望，因为它们的估值比构成她基金的颠覆性投资更高估。</blockquote></p><p> “Unlike many innovation-related stocks, equity benchmarks are selling at record high prices and near record high valuations, 26x for the S&amp;P 500 and 127x for the Nasdaq on a trailing twelve-month basis,” Wood wrote.</p><p><blockquote>伍德写道：“与许多与创新相关的股票不同，股票基准正以创纪录的高价和接近创纪录的高估值出售，过去12个月标普500为26倍，纳斯达克为127倍。”</blockquote></p><p> She said that the “five major innovation platforms which involve 14 technologies are likely to transform the existing world order and that so-called tried and true investment strategies “will disappoint during the next five to ten years as DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology scale and converge.”</p><p><blockquote>她表示，“涉及14项技术的五大创新平台可能会改变现有的世界秩序，随着DNA测序、机器人、能源存储、人工智能和区块链技术的规模和融合，所谓的屡试不爽的投资策略”将在未来五到十年内令人失望。”</blockquote></p><p> Wood also made the case that the so-called wall of worry, with inflation fears representing perhaps the biggest concern, provided an ideal backdrop for further advances in innovation stocks in the longer run because the dot-com markets of the late-1990s weren’t properly buffeted by investor concerns. The thinking is that “walls of worry” tend to limit market euphoria.</p><p><blockquote>伍德还指出，所谓的担忧墙（其中通胀担忧可能是最大的担忧）从长远来看为创新股的进一步上涨提供了理想的背景，因为20世纪90年代末的互联网市场并没有受到投资者担忧的适当打击。人们的想法是，“担忧之墙”往往会限制市场的兴奋。</blockquote></p><p> “In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space,” she wrote. “No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights,” Wood said.</p><p><blockquote>她写道：“我们认为，建立在高市盈率股票基础上的担忧之墙对创新领域的股票来说是个好兆头。”伍德表示：“1999年，股市并不存在担忧之墙，也没有受到考验。这一次，担忧之墙已经达到了巨大的高度。”</blockquote></p><p> On the macroeconomic front, Wood said that deflation, rather than inflation, could be a bigger problem for markets in the coming months.</p><p><blockquote>在宏观经济方面，伍德表示，通货紧缩而不是通胀可能是未来几个月市场面临的更大问题。</blockquote></p><p></p><p> “That said, my conviction is growing that the bigger surprise to the markets will be price deflation – both cyclical and secular – and that, after collapsing this year, higher multiple stocks could turn around dramatically during the next year,” she wrote.</p><p><blockquote>她写道：“也就是说，我越来越相信，市场面临的更大惊喜将是价格通货紧缩——无论是周期性的还是长期的——而且在今年崩溃之后，市盈率较高的股票可能会在明年大幅逆转。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/cathie-wood-says-stocks-have-corrected-into-deep-value-territory-and-wont-let-benchmarks-hold-our-strategies-hostage-11639795224?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉",".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index","TDOC":"Teladoc Health Inc.","ARKK":"ARK Innovation ETF"},"source_url":"https://www.marketwatch.com/story/cathie-wood-says-stocks-have-corrected-into-deep-value-territory-and-wont-let-benchmarks-hold-our-strategies-hostage-11639795224?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192708619","content_text":"ARK Invest founder Cathie Wood offered the latest defense of the once-highflying, disruptive innovation strategies that had made her suite of exchange-traded funds among the most popular, and best-performing, on Wall Street in 2020.\nPatrick T. Fallon/AFP/Getty Images\nIn a Friday evening blog post, Wood said that despite a brutal stretch that has compelled the operators of the ARK Invest ETFs, including the flagship Ark Innovation fund, to do some soul-searching, the fund manager is sticking to her game plan.\n\n “‘With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years.’”\n\n“We won’t let benchmarks and tracking errors hold our strategies hostage to the existing world order,” Wood wrote. She described the success of the ARK ETFs as one not solely bolstered by fervor for “stay at home” investment opportunities, amid the COVID pandemic, but rooted in identifying paradigm-shifting innovation, from blockchain and bitcoin to electric vehicles.\n“Critical to investment success will be moving to the right side of change, avoiding industries and companies caught in the crosshairs of ‘creative destruction’ and embracing those on the leading edge of ‘disruptive innovation,'” Wood wrote.\nOn Friday, ARK Innovation ended the session up nearly 6% and produced its second straight sharp weekly gain, up 1.1%, following a 1.8% advance in the prior week. The advance for ARK Innovation still leaves the actively managed fund down nearly 22% in the year to date, as the broader S&P 500,the Dow Jones Industrial Average and the technology Nasdaq Composite Index have faced whipsawing volatility derived primarily from concerns about more transmissible strains of COVID, surging inflation and global monetary policy’s reaction to those pricing pressures. Year-to-date the S&P 500 index is up 864.57 points or 23.02%.\nARK’s seven ETFs returned an average of 141% in 2020, on the back of gains from companies such as Tesla Inc.,and Teladoc Health Inc., making Wood the toast of Wall Street. But those funds, focused primarily on companies that aren’t yet profitable, have been limping lower since hitting a peak back in February, and their woeful performance has raised questions about the prospects for the ETFs in the months and years to come.\nWood urged investors to maintain their support of the ARK complex and said that maintaining a long-term, five-year time horizon would be the best way to judge the fund manager’s true performance.\n“With a five-year investment time horizon, our forecasts for these platforms suggest that our strategies today could deliver a 30-40% compound annual rate of return during the next five years,” the ARK CEO wrote.\n“In other words, if our research is correct—and I believe that our research on innovation is the best in the financial world—then our strategies will triple to quintuple in value over the next five years,” Wood added.\nThe ARK founder also made the case that the Nasdaq and S&P 500 could be the bigger disappointment to return-eager investors in the longer-term because they are more overvalued than the disruptive investments that comprise her funds.\n“Unlike many innovation-related stocks, equity benchmarks are selling at record high prices and near record high valuations, 26x for the S&P 500 and 127x for the Nasdaq on a trailing twelve-month basis,” Wood wrote.\nShe said that the “five major innovation platforms which involve 14 technologies are likely to transform the existing world order and that so-called tried and true investment strategies “will disappoint during the next five to ten years as DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology scale and converge.”\nWood also made the case that the so-called wall of worry, with inflation fears representing perhaps the biggest concern, provided an ideal backdrop for further advances in innovation stocks in the longer run because the dot-com markets of the late-1990s weren’t properly buffeted by investor concerns. The thinking is that “walls of worry” tend to limit market euphoria.\n“In our view, the wall of worry built on the back of high multiple stocks bodes well for equities in the innovation space,” she wrote. “No wall of worry existed or tested the equity market in 1999. This time around, the wall of worry has scaled to enormous heights,” Wood said.\nOn the macroeconomic front, Wood said that deflation, rather than inflation, could be a bigger problem for markets in the coming months.\n“That said, my conviction is growing that the bigger surprise to the markets will be price deflation – both cyclical and secular – and that, after collapsing this year, higher multiple stocks could turn around dramatically during the next year,” she wrote.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,"TSLA":0.9,"TDOC":0.9,"ARKIU":0.9,"ARKK":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":2665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699387884,"gmtCreate":1639750034660,"gmtModify":1639750034731,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Agree for a change.. adding both DCA","listText":"Agree for a change.. adding both DCA","text":"Agree for a change.. adding both DCA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699387884","repostId":"2192783759","repostType":2,"isVote":1,"tweetType":1,"viewCount":3738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607555922,"gmtCreate":1639568936763,"gmtModify":1639570838885,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Waiting to enter leaps call around 130 or below","listText":"Waiting to enter leaps call around 130 or below","text":"Waiting to enter leaps call around 130 or below","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607555922","repostId":"1139959073","repostType":4,"isVote":1,"tweetType":1,"viewCount":2346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607550642,"gmtCreate":1639568057454,"gmtModify":1639568057750,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Uff time for me to exit Xpeng.. ARK ETF’s are good candidates of shorting.. this is completely my view","listText":"Uff time for me to exit Xpeng.. ARK ETF’s are good candidates of shorting.. this is completely my view","text":"Uff time for me to exit Xpeng.. ARK ETF’s are good candidates of shorting.. this is completely my view","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607550642","repostId":"1160618167","repostType":2,"repost":{"id":"1160618167","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639551825,"share":"https://www.laohu8.com/m/news/1160618167?lang=zh_CN&edition=full","pubTime":"2021-12-15 15:03","market":"us","language":"en","title":"Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival<blockquote>凯西·伍德(Cathie Wood)在这家中国特斯拉竞争对手身上又投入了430万美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160618167","media":"Benzinga","summary":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in t","content":"<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p><p><blockquote>受欢迎的投资管理公司<b>方舟投资，</b>由<b>凯西·伍德，</b>周二，购买了更多在美国上市的中国电动汽车制造商的股票<b>小鹏汽车</b>（纽约证券交易所股票代码：XPEV）下跌。</blockquote></p><p> Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p><p><blockquote>Ark Invest购买了总部位于中国广州的小鹏汽车97,697股股票，估计价值434万美元。</blockquote></p><p> Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p><p><blockquote>小鹏汽车股价周二收盘下跌1.92%，至每股44.47美元，过去五天累计下跌7.35%。</blockquote></p><p> Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p><p><blockquote>小鹏汽车和其他中国同行股票，例如<b>蔚来公司</b>（纽约证券交易所股票代码：蔚来）最近面临压力。</blockquote></p><p> Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p><p><blockquote>小鹏汽车领先于当地竞争对手蔚来和<b>理想汽车公司</b>（纳斯达克：LI）报告11月份交付量时的月度销量。</blockquote></p><p> Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p><p><blockquote>这三家公司均表示，他们交付了超过10,000辆电动汽车，其中小鹏汽车以15,613辆领先，理想汽车以13,485辆位居第二，蔚来本月向经销商交付了10,878辆。</blockquote></p><p> Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p><p><blockquote>小鹏汽车董事长顾布莱恩上个月表示，该公司的目标是将一半的电动汽车销往中国境外。</blockquote></p><p> The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p><p><blockquote>这家电动轿车和SUV制造商已经在挪威销售电动汽车，并计划明年加大海外投资，包括瑞典、丹麦和荷兰。</blockquote></p><p> Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p><p><blockquote>Ark Invest通过<b>ARKA自主技术与机器人ETF</b>.</blockquote></p><p> ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p><p><blockquote>在周二交易之前，ARKQ持有小鹏汽车524,034股股票，价值2,374万美元。</blockquote></p><p> <b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p><p><blockquote><b>特斯拉公司</b>是Ark Invest大额买入的唯一一家全电动汽车制造商。该公司将特斯拉视为其最大持股，并通过其交易所交易基金持有该公司价值数十亿美元的股票。</blockquote></p><p> The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p><p><blockquote>自9月初该公司股价开始上涨以来，该投资公司一直在特斯拉实现盈利。</blockquote></p><p> Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p><p><blockquote>特斯拉股价已跌破1,000美元水平，其市值目前也低于1万亿美元。</blockquote></p><p> Here are a few other key Ark trades from Tuesday:</p><p><blockquote>以下是周二的其他一些关键方舟交易：</blockquote></p><p> <ul>  <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>  <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li> </ul></p><p><blockquote><ul><li>购买了11,671股股票——估计价值300万美元<b>Coinbase</b> <b>全球公司</b>该股周二收涨1.79%，报每股255.86美元。</li><li>出售56,925股，估计价值440万美元<b>京东公司</b>该股收跌0.51%，报每股77.65美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival<blockquote>凯西·伍德(Cathie Wood)在这家中国特斯拉竞争对手身上又投入了430万美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Loads Up Another $4.3M In This Chinese Tesla Rival<blockquote>凯西·伍德(Cathie Wood)在这家中国特斯拉竞争对手身上又投入了430万美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-12-15 15:03</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Popular investment&nbsp;management firm&nbsp;<b>Ark Invest,</b>led by&nbsp;<b>Cathie Wood,</b>on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker&nbsp;<b>Xpeng Inc</b>(NYSE:XPEV) on the dip.</p><p><blockquote>受欢迎的投资管理公司<b>方舟投资，</b>由<b>凯西·伍德，</b>周二，购买了更多在美国上市的中国电动汽车制造商的股票<b>小鹏汽车</b>（纽约证券交易所股票代码：XPEV）下跌。</blockquote></p><p> Ark Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.</p><p><blockquote>Ark Invest购买了总部位于中国广州的小鹏汽车97,697股股票，估计价值434万美元。</blockquote></p><p> Xpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.</p><p><blockquote>小鹏汽车股价周二收盘下跌1.92%，至每股44.47美元，过去五天累计下跌7.35%。</blockquote></p><p> Xpeng and other Chinese peer shares such as&nbsp;<b>Nio Inc</b>(NYSE:NIO) have been under pressure recently.</p><p><blockquote>小鹏汽车和其他中国同行股票，例如<b>蔚来公司</b>（纽约证券交易所股票代码：蔚来）最近面临压力。</blockquote></p><p> Xpeng bolted ahead of local rivals Nio and&nbsp;<b>Li Auto Inc</b>(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.</p><p><blockquote>小鹏汽车领先于当地竞争对手蔚来和<b>理想汽车公司</b>（纳斯达克：LI）报告11月份交付量时的月度销量。</blockquote></p><p> Each of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.</p><p><blockquote>这三家公司均表示，他们交付了超过10,000辆电动汽车，其中小鹏汽车以15,613辆领先，理想汽车以13,485辆位居第二，蔚来本月向经销商交付了10,878辆。</blockquote></p><p> Xpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.</p><p><blockquote>小鹏汽车董事长顾布莱恩上个月表示，该公司的目标是将一半的电动汽车销往中国境外。</blockquote></p><p> The maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.</p><p><blockquote>这家电动轿车和SUV制造商已经在挪威销售电动汽车，并计划明年加大海外投资，包括瑞典、丹麦和荷兰。</blockquote></p><p> Ark Invest bought shares in Xpeng via the&nbsp;<b>ArkAutonomous Technology &amp; Robotics ETF</b>.</p><p><blockquote>Ark Invest通过<b>ARKA自主技术与机器人ETF</b>.</blockquote></p><p> ARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.</p><p><blockquote>在周二交易之前，ARKQ持有小鹏汽车524,034股股票，价值2,374万美元。</blockquote></p><p> <b>Tesla Inc</b>&nbsp;is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.</p><p><blockquote><b>特斯拉公司</b>是Ark Invest大额买入的唯一一家全电动汽车制造商。该公司将特斯拉视为其最大持股，并通过其交易所交易基金持有该公司价值数十亿美元的股票。</blockquote></p><p> The investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.</p><p><blockquote>自9月初该公司股价开始上涨以来，该投资公司一直在特斯拉实现盈利。</blockquote></p><p> Tesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.</p><p><blockquote>特斯拉股价已跌破1,000美元水平，其市值目前也低于1万亿美元。</blockquote></p><p> Here are a few other key Ark trades from Tuesday:</p><p><blockquote>以下是周二的其他一些关键方舟交易：</blockquote></p><p> <ul>  <li>Bought 11,671 shares — estimated to be worth $3 million — in&nbsp;<b>Coinbase</b>&nbsp;<b>Global Inc</b>. The stock closed 1.79% higher at $255.86 a share on Tuesday.</li>  <li>Sold 56,925 shares — estimated to be worth $4.4 million — in<b>JD.com Inc</b>. The stock closed 0.51% lower at $77.65 a share.</li> </ul></p><p><blockquote><ul><li>购买了11,671股股票——估计价值300万美元<b>Coinbase</b> <b>全球公司</b>该股周二收涨1.79%，报每股255.86美元。</li><li>出售56,925股，估计价值440万美元<b>京东公司</b>该股收跌0.51%，报每股77.65美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车","JD":"京东","ARKQ":"ARK Autonomous Technology & Robotics ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160618167","content_text":"Popular investment management firm Ark Invest,led by Cathie Wood,on Tuesday, bought more shares in the U.S. listed Chinese electric vehicle maker Xpeng Inc(NYSE:XPEV) on the dip.\nArk Invest bought 97,697 shares — estimated to be worth $4.34 million — in the Guangzhou, China-based Xpeng.\nXpeng’s stock closed 1.92% lower at $44.47 a share on Tuesday and has fallen 7.35% in the past five days.\nXpeng and other Chinese peer shares such as Nio Inc(NYSE:NIO) have been under pressure recently.\nXpeng bolted ahead of local rivals Nio and Li Auto Inc(NASDAQ:LI) in terms of monthly volume when it reported November deliveries.\nEach of the three players said they delivered more than 10,000 electric vehicles — with Xpeng leading the pack at 15,613 units, Li Auto grabbing the second spot at 13,485 units and Nio dispatching 10,878 units to dealers during the month.\nXpeng Chairman Brian Gu last month said the company aims to sell half of its electric vehicles outside of China.\nThe maker of electric sedans and SUVs already sells electric vehicles in Norway and plans to ramp up investments overseas next year, including in Sweden, Denmark and the Netherlands.\nArk Invest bought shares in Xpeng via the ArkAutonomous Technology & Robotics ETF.\nARKQ held 524,034 shares — worth $23.74 million in Xpeng, prior to Tuesday’s trade.\nTesla Inc is the only other all-electric vehicle manufacturer in which Ark Invest has bought large amounts. The firm counts Tesla as its largest holding and owns shares worth billions in the company via its exchange-traded funds.\nThe investment firm has been booking profit in Tesla since early September when shares of the company began an upward march.\nTesla stock has slipped below the $1,000 levels and its market cap is now below $1-trillion as well.\nHere are a few other key Ark trades from Tuesday:\n\nBought 11,671 shares — estimated to be worth $3 million — in Coinbase Global Inc. The stock closed 1.79% higher at $255.86 a share on Tuesday.\nSold 56,925 shares — estimated to be worth $4.4 million — inJD.com Inc. The stock closed 0.51% lower at $77.65 a share.","news_type":1,"symbols_score_info":{"ARKQ":0,"XPEV":0,"JD":0}},"isVote":1,"tweetType":1,"viewCount":2544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608507755,"gmtCreate":1638755224231,"gmtModify":1638755224231,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","listText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","text":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608507755","repostId":"1107533977","repostType":4,"repost":{"id":"1107533977","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638754268,"share":"https://www.laohu8.com/m/news/1107533977?lang=zh_CN&edition=full","pubTime":"2021-12-06 09:31","market":"us","language":"en","title":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107533977","media":"Tiger Newspress","summary":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","content":"<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港下跌超过14%，小鹏汽车下跌近9%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLi Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 09:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港下跌超过14%，小鹏汽车下跌近9%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","XPEV":"小鹏汽车","09868":"小鹏汽车-W","02015":"理想汽车-W"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107533977","content_text":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","news_type":1,"symbols_score_info":{"09868":0.9,"02015":0.9,"LI":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":3498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603029630,"gmtCreate":1638342089689,"gmtModify":1638342098661,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Pump and dump cathie ..","listText":"Pump and dump cathie ..","text":"Pump and dump cathie ..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603029630","repostId":"2188553204","repostType":4,"isVote":1,"tweetType":1,"viewCount":2252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873415599,"gmtCreate":1636975301716,"gmtModify":1636975301716,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","listText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","text":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873415599","repostId":"2183046479","repostType":4,"isVote":1,"tweetType":1,"viewCount":3647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842072401,"gmtCreate":1636122794708,"gmtModify":1636122794836,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"For a change I agree.. Starbucks! but they need to evolve if they want to survive&nbsp;","listText":"For a change I agree.. Starbucks! but they need to evolve if they want to survive&nbsp;","text":"For a change I agree.. Starbucks! but they need to evolve if they want to survive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842072401","repostId":"1156284404","repostType":4,"repost":{"id":"1156284404","kind":"news","pubTimestamp":1636121042,"share":"https://www.laohu8.com/m/news/1156284404?lang=zh_CN&edition=full","pubTime":"2021-11-05 22:04","market":"us","language":"en","title":"Better Buy: Disney vs. Starbucks<blockquote>更值得购买：迪士尼与星巴克</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156284404","media":"Motley Fool ","summary":"Both have strong brands, but one gets the nod.","content":"<p>It is always difficult to choose between two high-quality companies. Ideally, you might like to purchase both. Yet, frequently investing comes down to where to put your hard-earned money.</p><p><blockquote>在两家优质公司之间总是很难做出选择。理想情况下，你可能想两者都买。然而，投资往往归结为把你的血汗钱放在哪里。</blockquote></p><p> That's the case with&nbsp;<b>Walt Disney</b>&nbsp;and&nbsp;<b>Starbucks</b>. Both stocks have had a challenging 2021. Disney's share price is down 6%, while Starbucks' stock has dropped by 5%. This comes as the&nbsp;<b>S&amp;P 500</b>&nbsp;has risen by 24% during that time.</p><p><blockquote>情况就是这样<b>迪斯尼</b>和<b>星巴克</b>两只股票都经历了充满挑战的2021年。迪士尼股价下跌6%，星巴克股价下跌5%。这是作为<b>标普500</b>在此期间上涨了24%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/92d7cd6a38784299fa1cce99ae01a4cd\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> However, both offer investors solid long-term growth prospects. The question is: Which one is the better investment right now?</p><p><blockquote>然而，两者都为投资者提供了坚实的长期增长前景。问题是：目前哪一项是更好的投资？</blockquote></p><p> <b>Starbucks</b></p><p><blockquote><b>星巴克</b></blockquote></p><p> Investors clearly didn't like Starbucks' latest quarterly earnings report. Following the late-October release, they sent the stock down by 6% to about $106. The issue stemmed from&nbsp;higher costs&nbsp;that will likely continue weighing on near-term profitability.</p><p><blockquote>投资者显然不喜欢星巴克最新的季度收益报告。10月底发布后，该股下跌6%，至106美元左右。这个问题源于成本上升，这可能会继续影响近期盈利能力。</blockquote></p><p> In the latest quarter, Starbucks' operating margin under&nbsp;U.S. generally accepted accounting principles(GAAP) more than doubled to 18.2%. But for next year, management expects a 17% margin, largely due to higher wages. While this is below its 18% to 19% long-term target, I believe this will prove temporary.</p><p><blockquote>最近一个季度，星巴克在美国的营业利润率。公认会计原则(GAAP)增长了一倍多，达到18.2%。但管理层预计明年的利润率为17%，这主要是由于工资上涨。虽然这低于18%至19%的长期目标，但我相信这将是暂时的。</blockquote></p><p> That's because Starbucks continues to post strong sales growth. That will help the company increase prices and leverage expenses.</p><p><blockquote>这是因为星巴克继续保持强劲的销售增长。这将有助于公司提高价格并利用费用。</blockquote></p><p> Starbucks' quarterly revenue rose by 31% to $8.1 billion, driven by new restaurant openings and a 17% increase in same-store sales. For fiscal 2022, management expects a high single-digit percentage increase in comps and to open 2,000 restaurants, mostly outside of the U.S. It anticipates these will lead to revenue of $32.5 billion to $33 billion,</p><p><blockquote>受新餐厅开业和同店销售额增长17%的推动，星巴克季度营收增长31%至81亿美元。对于2022财年，管理层预计comps将实现高个位数百分比增长，并将开设2,000家餐厅，其中大部分在美国境外。预计这些将带来325亿至330亿美元的收入，</blockquote></p><p> In short, demand for Starbucks' products, which took a pause during the pandemic due to store closures, remains strong.</p><p><blockquote>简而言之，对星巴克产品的需求在疫情期间因商店关闭而暂停，但仍然强劲。</blockquote></p><p> <b>Walt Disney</b></p><p><blockquote><b>迪斯尼</b></blockquote></p><p> Disney's shares have fallen this year due to concerns about&nbsp;slowing growth at Disney+, its streaming service. As it grew by leaps and bounds during the pandemic, I'm not concerned.</p><p><blockquote>由于担心其流媒体服务Disney+增长放缓，迪士尼股价今年下跌。由于它在疫情期间突飞猛进，我并不担心。</blockquote></p><p> After all, Disney+ had 116 million paid subscribers at the start of July 2021, compared to 103.6 million in April. This is also more than double the 57.5 million from a year ago.</p><p><blockquote>毕竟，截至2021年7月初，Disney+的付费用户为1.16亿，而4月份为1.036亿。这也是一年前5750万的两倍多。</blockquote></p><p> While it may not have the supersonic growth of the past, Disney+ is still adding subscribers at a nice pace. What's more, Disney is far more than a streaming service. Its vast media empire includes parks, movies, several television networks, and retail stores.</p><p><blockquote>虽然Disney+可能没有过去的超音速增长，但它仍在以不错的速度增加订户。更重要的是，迪士尼不仅仅是一个流媒体服务。其庞大的媒体帝国包括公园、电影、几个电视网络和零售店。</blockquote></p><p> This helps the company produce strong results, even if one part of the business slows. For instance, this year saw the return of live sports that helped its ESPN network, and theme parks reopened. Its quarterly revenue grew by 45% to $17 billion year over year.</p><p><blockquote>这有助于公司取得强劲的业绩，即使业务的一部分放缓。例如，今年帮助其ESPN网络的体育直播回归，主题公园重新开放。其季度收入同比增长45%，达到170亿美元。</blockquote></p><p> With popular media properties, such as a stable of Marvel characters and movies, the future looks bright for Disney. That's because it has highly recognized and well-regarded brands that have proven their staying power. Management has strengthened its position, including buying Twenty-First Century Fox a couple of years ago, which added television networks, Marvel characters, and provided a controlling interest in the streaming service Hulu.</p><p><blockquote>凭借受欢迎的媒体资产，如漫威角色和电影的稳定，迪士尼的未来看起来一片光明。这是因为它拥有高度认可和备受推崇的品牌，这些品牌已经证明了它们的持久力。管理层加强了其地位，包括几年前收购了二十一世纪福克斯公司，该公司增加了电视网络、漫威角色，并提供了流媒体服务Hulu的控股权。</blockquote></p><p> After examining both companies, both have strong brands that attract a lot of people. For me, the edge goes to Starbucks, since it has increased dividends since 2010, including during the pandemic. It's nice to receive the income, and it's a positive sign that management and the board of directors have confidence in the future.</p><p><blockquote>考察了两家公司后，两家公司都有吸引很多人的强大品牌。对我来说，优势在于星巴克，因为它自2010年以来增加了股息，包括在大流行期间。很高兴收到收入，这是管理层和董事会对未来有信心的积极迹象。</blockquote></p><p> Unfortunately, Disney suspended its dividend last year. While that's certainly understandable given the uncertainty created by the pandemic, it does give a leg up to Starbucks, which saw fit to increase payments.</p><p><blockquote>不幸的是，迪士尼去年暂停了股息。虽然考虑到疫情造成的不确定性，这当然是可以理解的，但这确实给星巴克带来了帮助，星巴克认为增加支付是合适的。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: Disney vs. Starbucks<blockquote>更值得购买：迪士尼与星巴克</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: Disney vs. Starbucks<blockquote>更值得购买：迪士尼与星巴克</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool </strong><span class=\"h-time small\">2021-11-05 22:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It is always difficult to choose between two high-quality companies. Ideally, you might like to purchase both. Yet, frequently investing comes down to where to put your hard-earned money.</p><p><blockquote>在两家优质公司之间总是很难做出选择。理想情况下，你可能想两者都买。然而，投资往往归结为把你的血汗钱放在哪里。</blockquote></p><p> That's the case with&nbsp;<b>Walt Disney</b>&nbsp;and&nbsp;<b>Starbucks</b>. Both stocks have had a challenging 2021. Disney's share price is down 6%, while Starbucks' stock has dropped by 5%. This comes as the&nbsp;<b>S&amp;P 500</b>&nbsp;has risen by 24% during that time.</p><p><blockquote>情况就是这样<b>迪斯尼</b>和<b>星巴克</b>两只股票都经历了充满挑战的2021年。迪士尼股价下跌6%，星巴克股价下跌5%。这是作为<b>标普500</b>在此期间上涨了24%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/92d7cd6a38784299fa1cce99ae01a4cd\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p> However, both offer investors solid long-term growth prospects. The question is: Which one is the better investment right now?</p><p><blockquote>然而，两者都为投资者提供了坚实的长期增长前景。问题是：目前哪一项是更好的投资？</blockquote></p><p> <b>Starbucks</b></p><p><blockquote><b>星巴克</b></blockquote></p><p> Investors clearly didn't like Starbucks' latest quarterly earnings report. Following the late-October release, they sent the stock down by 6% to about $106. The issue stemmed from&nbsp;higher costs&nbsp;that will likely continue weighing on near-term profitability.</p><p><blockquote>投资者显然不喜欢星巴克最新的季度收益报告。10月底发布后，该股下跌6%，至106美元左右。这个问题源于成本上升，这可能会继续影响近期盈利能力。</blockquote></p><p> In the latest quarter, Starbucks' operating margin under&nbsp;U.S. generally accepted accounting principles(GAAP) more than doubled to 18.2%. But for next year, management expects a 17% margin, largely due to higher wages. While this is below its 18% to 19% long-term target, I believe this will prove temporary.</p><p><blockquote>最近一个季度，星巴克在美国的营业利润率。公认会计原则(GAAP)增长了一倍多，达到18.2%。但管理层预计明年的利润率为17%，这主要是由于工资上涨。虽然这低于18%至19%的长期目标，但我相信这将是暂时的。</blockquote></p><p> That's because Starbucks continues to post strong sales growth. That will help the company increase prices and leverage expenses.</p><p><blockquote>这是因为星巴克继续保持强劲的销售增长。这将有助于公司提高价格并利用费用。</blockquote></p><p> Starbucks' quarterly revenue rose by 31% to $8.1 billion, driven by new restaurant openings and a 17% increase in same-store sales. For fiscal 2022, management expects a high single-digit percentage increase in comps and to open 2,000 restaurants, mostly outside of the U.S. It anticipates these will lead to revenue of $32.5 billion to $33 billion,</p><p><blockquote>受新餐厅开业和同店销售额增长17%的推动，星巴克季度营收增长31%至81亿美元。对于2022财年，管理层预计comps将实现高个位数百分比增长，并将开设2,000家餐厅，其中大部分在美国境外。预计这些将带来325亿至330亿美元的收入，</blockquote></p><p> In short, demand for Starbucks' products, which took a pause during the pandemic due to store closures, remains strong.</p><p><blockquote>简而言之，对星巴克产品的需求在疫情期间因商店关闭而暂停，但仍然强劲。</blockquote></p><p> <b>Walt Disney</b></p><p><blockquote><b>迪斯尼</b></blockquote></p><p> Disney's shares have fallen this year due to concerns about&nbsp;slowing growth at Disney+, its streaming service. As it grew by leaps and bounds during the pandemic, I'm not concerned.</p><p><blockquote>由于担心其流媒体服务Disney+增长放缓，迪士尼股价今年下跌。由于它在疫情期间突飞猛进，我并不担心。</blockquote></p><p> After all, Disney+ had 116 million paid subscribers at the start of July 2021, compared to 103.6 million in April. This is also more than double the 57.5 million from a year ago.</p><p><blockquote>毕竟，截至2021年7月初，Disney+的付费用户为1.16亿，而4月份为1.036亿。这也是一年前5750万的两倍多。</blockquote></p><p> While it may not have the supersonic growth of the past, Disney+ is still adding subscribers at a nice pace. What's more, Disney is far more than a streaming service. Its vast media empire includes parks, movies, several television networks, and retail stores.</p><p><blockquote>虽然Disney+可能没有过去的超音速增长，但它仍在以不错的速度增加订户。更重要的是，迪士尼不仅仅是一个流媒体服务。其庞大的媒体帝国包括公园、电影、几个电视网络和零售店。</blockquote></p><p> This helps the company produce strong results, even if one part of the business slows. For instance, this year saw the return of live sports that helped its ESPN network, and theme parks reopened. Its quarterly revenue grew by 45% to $17 billion year over year.</p><p><blockquote>这有助于公司取得强劲的业绩，即使业务的一部分放缓。例如，今年帮助其ESPN网络的体育直播回归，主题公园重新开放。其季度收入同比增长45%，达到170亿美元。</blockquote></p><p> With popular media properties, such as a stable of Marvel characters and movies, the future looks bright for Disney. That's because it has highly recognized and well-regarded brands that have proven their staying power. Management has strengthened its position, including buying Twenty-First Century Fox a couple of years ago, which added television networks, Marvel characters, and provided a controlling interest in the streaming service Hulu.</p><p><blockquote>凭借受欢迎的媒体资产，如漫威角色和电影的稳定，迪士尼的未来看起来一片光明。这是因为它拥有高度认可和备受推崇的品牌，这些品牌已经证明了它们的持久力。管理层加强了其地位，包括几年前收购了二十一世纪福克斯公司，该公司增加了电视网络、漫威角色，并提供了流媒体服务Hulu的控股权。</blockquote></p><p> After examining both companies, both have strong brands that attract a lot of people. For me, the edge goes to Starbucks, since it has increased dividends since 2010, including during the pandemic. It's nice to receive the income, and it's a positive sign that management and the board of directors have confidence in the future.</p><p><blockquote>考察了两家公司后，两家公司都有吸引很多人的强大品牌。对我来说，优势在于星巴克，因为它自2010年以来增加了股息，包括在大流行期间。很高兴收到收入，这是管理层和董事会对未来有信心的积极迹象。</blockquote></p><p> Unfortunately, Disney suspended its dividend last year. While that's certainly understandable given the uncertainty created by the pandemic, it does give a leg up to Starbucks, which saw fit to increase payments.</p><p><blockquote>不幸的是，迪士尼去年暂停了股息。虽然考虑到疫情造成的不确定性，这当然是可以理解的，但这确实给星巴克带来了帮助，星巴克认为增加支付是合适的。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/11/05/better-buy-disney-vs-starbucks/\">Motley Fool </a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克","DIS":"迪士尼"},"source_url":"https://www.fool.com/investing/2021/11/05/better-buy-disney-vs-starbucks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156284404","content_text":"It is always difficult to choose between two high-quality companies. Ideally, you might like to purchase both. Yet, frequently investing comes down to where to put your hard-earned money.\nThat's the case with Walt Disney and Starbucks. Both stocks have had a challenging 2021. Disney's share price is down 6%, while Starbucks' stock has dropped by 5%. This comes as the S&P 500 has risen by 24% during that time.\nIMAGE SOURCE: GETTY IMAGES.\nHowever, both offer investors solid long-term growth prospects. The question is: Which one is the better investment right now?\nStarbucks\nInvestors clearly didn't like Starbucks' latest quarterly earnings report. Following the late-October release, they sent the stock down by 6% to about $106. The issue stemmed from higher costs that will likely continue weighing on near-term profitability.\nIn the latest quarter, Starbucks' operating margin under U.S. generally accepted accounting principles(GAAP) more than doubled to 18.2%. But for next year, management expects a 17% margin, largely due to higher wages. While this is below its 18% to 19% long-term target, I believe this will prove temporary.\nThat's because Starbucks continues to post strong sales growth. That will help the company increase prices and leverage expenses.\nStarbucks' quarterly revenue rose by 31% to $8.1 billion, driven by new restaurant openings and a 17% increase in same-store sales. For fiscal 2022, management expects a high single-digit percentage increase in comps and to open 2,000 restaurants, mostly outside of the U.S. It anticipates these will lead to revenue of $32.5 billion to $33 billion,\nIn short, demand for Starbucks' products, which took a pause during the pandemic due to store closures, remains strong.\nWalt Disney\nDisney's shares have fallen this year due to concerns about slowing growth at Disney+, its streaming service. As it grew by leaps and bounds during the pandemic, I'm not concerned.\nAfter all, Disney+ had 116 million paid subscribers at the start of July 2021, compared to 103.6 million in April. This is also more than double the 57.5 million from a year ago.\nWhile it may not have the supersonic growth of the past, Disney+ is still adding subscribers at a nice pace. What's more, Disney is far more than a streaming service. Its vast media empire includes parks, movies, several television networks, and retail stores.\nThis helps the company produce strong results, even if one part of the business slows. For instance, this year saw the return of live sports that helped its ESPN network, and theme parks reopened. Its quarterly revenue grew by 45% to $17 billion year over year.\nWith popular media properties, such as a stable of Marvel characters and movies, the future looks bright for Disney. That's because it has highly recognized and well-regarded brands that have proven their staying power. Management has strengthened its position, including buying Twenty-First Century Fox a couple of years ago, which added television networks, Marvel characters, and provided a controlling interest in the streaming service Hulu.\nAfter examining both companies, both have strong brands that attract a lot of people. For me, the edge goes to Starbucks, since it has increased dividends since 2010, including during the pandemic. It's nice to receive the income, and it's a positive sign that management and the board of directors have confidence in the future.\nUnfortunately, Disney suspended its dividend last year. While that's certainly understandable given the uncertainty created by the pandemic, it does give a leg up to Starbucks, which saw fit to increase payments.","news_type":1,"symbols_score_info":{"SBUX":0.9,"DIS":0.9}},"isVote":1,"tweetType":1,"viewCount":3139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848990182,"gmtCreate":1635951643936,"gmtModify":1635951644045,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Nio is bear market 🤔","listText":"Nio is bear market 🤔","text":"Nio is bear market 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848990182","repostId":"2180378727","repostType":2,"isVote":1,"tweetType":1,"viewCount":797,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863837574,"gmtCreate":1632372393698,"gmtModify":1632800833000,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Suggestions on Adobe buy, am ready to add 30%","listText":"Suggestions on Adobe buy, am ready to add 30%","text":"Suggestions on Adobe buy, am ready to add 30%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/863837574","repostId":"1137784790","repostType":4,"repost":{"id":"1137784790","kind":"news","pubTimestamp":1632369156,"share":"https://www.laohu8.com/m/news/1137784790?lang=zh_CN&edition=full","pubTime":"2021-09-23 11:52","market":"us","language":"en","title":"5 Stocks to Buy in the September Sell-Off<blockquote>9月抛售中值得买入的5只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1137784790","media":"Motley Fool","summary":"History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.I can't tell you where Adobe,Markel,Take Two Interactive Software,Vertex Pharmaceuticals, and BostonBeerwill trade next week or next month. But I'm confident they will significantly outperform the market o","content":"<p>History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.</p><p><blockquote>历史表明，市场抛售是将优质公司添加到您的投资组合中的绝佳时机。虽然没有人能预测这种情况何时会发生，但10%的下降大约每两年发生一次。这就是为什么如果最近的低迷持续下去，我会重点介绍五家值得买入的优质公司。</blockquote></p><p> I&nbsp;can't&nbsp;tell&nbsp;you&nbsp;where&nbsp;<b>Adobe</b>(NASDAQ:ADBE),<b>Markel</b>(NYSE:MKL),<b>Take Two Interactive Software</b>(NASDAQ:TTWO),<b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX), and&nbsp;<b>BostonBeer</b>(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.</p><p><blockquote>我不能告诉你在哪里<b>土坯</b>（纳斯达克：ADBE），<b>马克尔</b>（纽约证券交易所代码：MKL），<b>拿两个互动软件</b>（纳斯达克：TTWO），<b>顶点制药</b>（纳斯达克：VRTX），以及<b>波士顿啤酒</b>（纽约证券交易所代码：SAM）将于下周或下个月交易。但我相信它们在未来三年多的时间里将显着跑赢市场。原因如下。</blockquote></p><p> <h3>Adobe</h3> At a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.</p><p><blockquote><h3>土坯</h3>Adobe的市值为3000亿美元，是全球最大的软件公司之一。它的应用程序是创意专业人士制作的许多内容的支柱。多年来，它还赋予了他们管理、衡量和货币化产出的能力。该公司将其业绩分为三类。</blockquote></p><p> Digital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.</p><p><blockquote>数字媒体包括该公司的创意云产品。这是一种订阅服务，为几乎任何创建或交付内容的人提供应用程序。数字体验部门是一个云平台，帮助公司提供最具吸引力的客户体验。它提供从营销管理和自动化到数字商务和预测分析的一切。最后，除了广告云产品之外，其出版和广告部门还包含遗留产品。</blockquote></p><p> The business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better than<b>Microsoft</b>.</p><p><blockquote>这项业务表现得非常好。过去十年，销售额和自由现金流分别增长了241%和281%。2021财年前9个月，该公司的收入为117亿美元。这比去年同期增长24%，比2019年增长43%。它几乎没有债务，投资资本回报率为33%。这比稍微好一点<b>微软</b>.</blockquote></p><p> CEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.</p><p><blockquote>首席执行官Shantanu Narayen看到了整个业务的实力，并相信数字化转型将推动公司的财务业绩，即使公司投资于其评级的“巨大市场机会”。毫无疑问，跑道很长。这就是为什么我认为任何重大抛售都是给投资者的礼物。如果您获得它并购买Adobe股票，请充分利用它。</blockquote></p><p> <h3>Markel</h3> Markel has been called the \"baby Berkshire\" for its resemblance to&nbsp;<b>Berkshire Hathaway</b>. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.</p><p><blockquote><h3>马克尔</h3>马克尔被称为“小伯克希尔”，因为它与<b>伯克希尔哈撒韦</b>它也是一家保险公司，利用其部分流通量——从索赔中未支付的保单中收取的保费——投资股票和收购企业。它也以类似的方式管理这些业务，将其持有期视为永远。</blockquote></p><p> One big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.</p><p><blockquote>一个很大的区别是Markel只是一家价值165亿美元的公司。这使其在购买商品方面具有更大的灵活性，并有可能为股东提供数十年稳定、跑赢市场的回报。想要证据吗？如果您发现马克尔的股票自1990年以来表现优于伯克希尔哈撒韦公司，您会感到惊讶吗？是的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/263e423c73746672c28109121ec6d687\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>MKLDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>MKL数据来自YCharts</span></p></blockquote></p><p> At less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.</p><p><blockquote>马克尔的规模还不到沃伦·巴菲特这个庞然大物的37倍，但他仍然有几乎无限的机会采用同样的模式。它可能不是一只令人兴奋的科技股，也不是一只在短时间内让您的投资翻倍，但它是一家经过验证的跑赢市场的公司，可以为投资组合增添压舱石。如果您有机会在抛售期间增持股票，请抓住它。</blockquote></p><p> <h3>Take Two Interactive</h3> Take Two has one of the most popular video game franchises of all time --<i>Grand Theft Auto</i>. As of last year, the fifth installment in the series --<i>GTA V</i>-- was the third-best-selling video game ever. It trailed only<i>Minecraft</i>and<i>Tetris</i>. Want more proof? It took<i>GTA V</i>three days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performing<i>Harry Potter</i>movie, and<i>Avatar</i>. And the company has more in its stable.</p><p><blockquote><h3>采取两个互动</h3>Take Two拥有有史以来最受欢迎的电子游戏系列之一--<i>侠盗猎车手</i>截至去年，该系列的第五部--<i>GTA V</i>——是有史以来第三畅销的视频游戏。它只落后了<i>Minecraft</i>和<i>俄罗斯方块</i>.想要更多证据吗？它花了<i>GTA V</i>三天销售额达到10亿美元。这比最接近的、性能最好的视频游戏快五倍以上<i>哈利波特</i>电影，和<i>阿凡达</i>.而且公司还有更多。</blockquote></p><p> Another of its popular games -- the<i>NBA2K</i>series -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.</p><p><blockquote>它的另一个流行游戏——the<i>NBA 2K</i>系列-也因其波兰和商业上的成功而受到称赞。但Take Two让我兴奋的是这些游戏的共同点。它们都在虚拟世界中提供了身临其境的体验，在虚拟世界中，可能性似乎是无穷无尽的。随着元宇宙的讨论变得越来越主流，该公司已经证明它可以创建引人入胜的虚拟世界，用户可以在其中参与打造自己的体验以及他人的体验。它使公司在财务上脱颖而出。</blockquote></p><p> Since 2012, sales have grown 308%. That compares favorably to<b>Activision Blizzard</b>'s 70% and<b>Electronic Arts</b>' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.</p><p><blockquote>自2012年以来，销售额增长了308%。与<b>动视暴雪</b>的70%和<b>电子艺界</b>'36%.当然，那些出版商已经更加成熟了。尽管如此，这有助于强调为什么我认为Take Two是在市场抛售中值得买入的游戏制造商。</blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b89d7f36b549065b4545a0fa5c997d02\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>EA REVENUE (ANNUAL)DATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>EA收入（年度）数据BYYCHARTS</span></p></blockquote></p><p> <h3>Vertex Pharmaceuticals</h3> Some drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.</p><p><blockquote><h3>顶点制药</h3>一些制药商拥有涵盖许多疾病领域的治疗组合。其他人专注于一种疾病，并努力主导这一领域。这就是Vertex如何建立480亿美元的市值和67亿美元的年收入。该公司拥有四种已获批准的治疗囊性纤维化（一种导致器官粘液积聚的疾病）的药物，并治疗美国、欧洲、澳大利亚和加拿大83,000名患者中的大约一半。</blockquote></p><p> Management believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.</p><p><blockquote>管理层相信，通过在最近获得批准的市场成功实现药物商业化、在新市场获得批准以及在美国和欧洲推出最新的CF药物，它可以治疗另外30,000名患者。</blockquote></p><p> It has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration with<b>CRISPR Therapeutics</b>-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs with<b>Moderna</b>and Arbor Biotechnologies. It's a robust pipeline with a lot of potential.</p><p><blockquote>它还与其他生物技术公司合作，以保持其在CF的地位并探索新的增长机会。它斥资9亿美元购买了CTX001的控股权——它与<b>CRISPR疗法</b>——用于治疗镰状细胞病和β地中海贫血。该公司还有一种非阿片类疼痛治疗方法、一种针对肾脏疾病的药物以及一种针对1型糖尿病的干细胞衍生疗法正在临床试验中。Vertex还拥有临床前基于基因的项目<b>现代</b>和阿伯生物技术公司。这是一个强大的管道，具有很大的潜力。</blockquote></p><p> Despite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.</p><p><blockquote>尽管如此，华尔街并没有给予该公司太多信任。其市销率是自2012年（该公司开始销售第一种CF药物的那一年）以来的最低水平。分析师预计今明两年的销量将攀升，这使得折扣更加明显。凭借强大的CF基础和如此大的潜力，Vertex Pharmaceuticals可能已经是抢手货了。</blockquote></p><p> <h3>Boston Beer</h3> Riding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.</p><p><blockquote><h3>波士顿啤酒</h3>顺应酒精饮料行业的趋势就像坐过山车一样。多年来，美国人的口味发生了变化，葡萄酒、威士忌、烈性苹果酒、精酿啤酒和烈性苏打水轮流成为首选饮料。在很大程度上，无论什么流行，波士顿啤酒都能取得成功。但对于股东来说，这是一个跌宕起伏的旅程。该股在过去20年中经历了三次至少60%的下跌。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f60342c3cab8471f9e4dbd370f401b1\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><span>SAMDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>SAMDATA BYYCHARTS</span></p></blockquote></p><p> It's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.</p><p><blockquote>它现在正处于衰退之中，因为它的硬苏打水品牌在雪崩般的竞争中表现不佳。下跌后，该股为投资者提供了一个他们不常得到的机会。分析师仍预计今年营收为21.6亿美元。这使得预计市盈率低于3，接近2019年初以来的最低水平。</blockquote></p><p> Of course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.</p><p><blockquote>当然，在好转之前，情况可能会变得更糟。管理层在7月份大幅下调了盈利预测，然后在本月早些时候撤回了指引，称这将产生与该产品相关的冲销和费用。尽管这很可怕，但我打赌波士顿啤酒将重复其在经济低迷时期幸存下来、找到新趋势并在未来几年创下历史新高的历史。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks to Buy in the September Sell-Off<blockquote>9月抛售中值得买入的5只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks to Buy in the September Sell-Off<blockquote>9月抛售中值得买入的5只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-23 11:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p>History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.</p><p><blockquote>历史表明，市场抛售是将优质公司添加到您的投资组合中的绝佳时机。虽然没有人能预测这种情况何时会发生，但10%的下降大约每两年发生一次。这就是为什么如果最近的低迷持续下去，我会重点介绍五家值得买入的优质公司。</blockquote></p><p> I&nbsp;can't&nbsp;tell&nbsp;you&nbsp;where&nbsp;<b>Adobe</b>(NASDAQ:ADBE),<b>Markel</b>(NYSE:MKL),<b>Take Two Interactive Software</b>(NASDAQ:TTWO),<b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX), and&nbsp;<b>BostonBeer</b>(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.</p><p><blockquote>我不能告诉你在哪里<b>土坯</b>（纳斯达克：ADBE），<b>马克尔</b>（纽约证券交易所代码：MKL），<b>拿两个互动软件</b>（纳斯达克：TTWO），<b>顶点制药</b>（纳斯达克：VRTX），以及<b>波士顿啤酒</b>（纽约证券交易所代码：SAM）将于下周或下个月交易。但我相信它们在未来三年多的时间里将显着跑赢市场。原因如下。</blockquote></p><p> <h3>Adobe</h3> At a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.</p><p><blockquote><h3>土坯</h3>Adobe的市值为3000亿美元，是全球最大的软件公司之一。它的应用程序是创意专业人士制作的许多内容的支柱。多年来，它还赋予了他们管理、衡量和货币化产出的能力。该公司将其业绩分为三类。</blockquote></p><p> Digital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.</p><p><blockquote>数字媒体包括该公司的创意云产品。这是一种订阅服务，为几乎任何创建或交付内容的人提供应用程序。数字体验部门是一个云平台，帮助公司提供最具吸引力的客户体验。它提供从营销管理和自动化到数字商务和预测分析的一切。最后，除了广告云产品之外，其出版和广告部门还包含遗留产品。</blockquote></p><p> The business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better than<b>Microsoft</b>.</p><p><blockquote>这项业务表现得非常好。过去十年，销售额和自由现金流分别增长了241%和281%。2021财年前9个月，该公司的收入为117亿美元。这比去年同期增长24%，比2019年增长43%。它几乎没有债务，投资资本回报率为33%。这比稍微好一点<b>微软</b>.</blockquote></p><p> CEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.</p><p><blockquote>首席执行官Shantanu Narayen看到了整个业务的实力，并相信数字化转型将推动公司的财务业绩，即使公司投资于其评级的“巨大市场机会”。毫无疑问，跑道很长。这就是为什么我认为任何重大抛售都是给投资者的礼物。如果您获得它并购买Adobe股票，请充分利用它。</blockquote></p><p> <h3>Markel</h3> Markel has been called the \"baby Berkshire\" for its resemblance to&nbsp;<b>Berkshire Hathaway</b>. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.</p><p><blockquote><h3>马克尔</h3>马克尔被称为“小伯克希尔”，因为它与<b>伯克希尔哈撒韦</b>它也是一家保险公司，利用其部分流通量——从索赔中未支付的保单中收取的保费——投资股票和收购企业。它也以类似的方式管理这些业务，将其持有期视为永远。</blockquote></p><p> One big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.</p><p><blockquote>一个很大的区别是Markel只是一家价值165亿美元的公司。这使其在购买商品方面具有更大的灵活性，并有可能为股东提供数十年稳定、跑赢市场的回报。想要证据吗？如果您发现马克尔的股票自1990年以来表现优于伯克希尔哈撒韦公司，您会感到惊讶吗？是的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/263e423c73746672c28109121ec6d687\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>MKLDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>MKL数据来自YCharts</span></p></blockquote></p><p> At less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.</p><p><blockquote>马克尔的规模还不到沃伦·巴菲特这个庞然大物的37倍，但他仍然有几乎无限的机会采用同样的模式。它可能不是一只令人兴奋的科技股，也不是一只在短时间内让您的投资翻倍，但它是一家经过验证的跑赢市场的公司，可以为投资组合增添压舱石。如果您有机会在抛售期间增持股票，请抓住它。</blockquote></p><p> <h3>Take Two Interactive</h3> Take Two has one of the most popular video game franchises of all time --<i>Grand Theft Auto</i>. As of last year, the fifth installment in the series --<i>GTA V</i>-- was the third-best-selling video game ever. It trailed only<i>Minecraft</i>and<i>Tetris</i>. Want more proof? It took<i>GTA V</i>three days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performing<i>Harry Potter</i>movie, and<i>Avatar</i>. And the company has more in its stable.</p><p><blockquote><h3>采取两个互动</h3>Take Two拥有有史以来最受欢迎的电子游戏系列之一--<i>侠盗猎车手</i>截至去年，该系列的第五部--<i>GTA V</i>——是有史以来第三畅销的视频游戏。它只落后了<i>Minecraft</i>和<i>俄罗斯方块</i>.想要更多证据吗？它花了<i>GTA V</i>三天销售额达到10亿美元。这比最接近的、性能最好的视频游戏快五倍以上<i>哈利波特</i>电影，和<i>阿凡达</i>.而且公司还有更多。</blockquote></p><p> Another of its popular games -- the<i>NBA2K</i>series -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.</p><p><blockquote>它的另一个流行游戏——the<i>NBA 2K</i>系列-也因其波兰和商业上的成功而受到称赞。但Take Two让我兴奋的是这些游戏的共同点。它们都在虚拟世界中提供了身临其境的体验，在虚拟世界中，可能性似乎是无穷无尽的。随着元宇宙的讨论变得越来越主流，该公司已经证明它可以创建引人入胜的虚拟世界，用户可以在其中参与打造自己的体验以及他人的体验。它使公司在财务上脱颖而出。</blockquote></p><p> Since 2012, sales have grown 308%. That compares favorably to<b>Activision Blizzard</b>'s 70% and<b>Electronic Arts</b>' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.</p><p><blockquote>自2012年以来，销售额增长了308%。与<b>动视暴雪</b>的70%和<b>电子艺界</b>'36%.当然，那些出版商已经更加成熟了。尽管如此，这有助于强调为什么我认为Take Two是在市场抛售中值得买入的游戏制造商。</blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b89d7f36b549065b4545a0fa5c997d02\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>EA REVENUE (ANNUAL)DATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>EA收入（年度）数据BYYCHARTS</span></p></blockquote></p><p> <h3>Vertex Pharmaceuticals</h3> Some drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.</p><p><blockquote><h3>顶点制药</h3>一些制药商拥有涵盖许多疾病领域的治疗组合。其他人专注于一种疾病，并努力主导这一领域。这就是Vertex如何建立480亿美元的市值和67亿美元的年收入。该公司拥有四种已获批准的治疗囊性纤维化（一种导致器官粘液积聚的疾病）的药物，并治疗美国、欧洲、澳大利亚和加拿大83,000名患者中的大约一半。</blockquote></p><p> Management believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.</p><p><blockquote>管理层相信，通过在最近获得批准的市场成功实现药物商业化、在新市场获得批准以及在美国和欧洲推出最新的CF药物，它可以治疗另外30,000名患者。</blockquote></p><p> It has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration with<b>CRISPR Therapeutics</b>-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs with<b>Moderna</b>and Arbor Biotechnologies. It's a robust pipeline with a lot of potential.</p><p><blockquote>它还与其他生物技术公司合作，以保持其在CF的地位并探索新的增长机会。它斥资9亿美元购买了CTX001的控股权——它与<b>CRISPR疗法</b>——用于治疗镰状细胞病和β地中海贫血。该公司还有一种非阿片类疼痛治疗方法、一种针对肾脏疾病的药物以及一种针对1型糖尿病的干细胞衍生疗法正在临床试验中。Vertex还拥有临床前基于基因的项目<b>现代</b>和阿伯生物技术公司。这是一个强大的管道，具有很大的潜力。</blockquote></p><p> Despite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.</p><p><blockquote>尽管如此，华尔街并没有给予该公司太多信任。其市销率是自2012年（该公司开始销售第一种CF药物的那一年）以来的最低水平。分析师预计今明两年的销量将攀升，这使得折扣更加明显。凭借强大的CF基础和如此大的潜力，Vertex Pharmaceuticals可能已经是抢手货了。</blockquote></p><p> <h3>Boston Beer</h3> Riding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.</p><p><blockquote><h3>波士顿啤酒</h3>顺应酒精饮料行业的趋势就像坐过山车一样。多年来，美国人的口味发生了变化，葡萄酒、威士忌、烈性苹果酒、精酿啤酒和烈性苏打水轮流成为首选饮料。在很大程度上，无论什么流行，波士顿啤酒都能取得成功。但对于股东来说，这是一个跌宕起伏的旅程。该股在过去20年中经历了三次至少60%的下跌。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f60342c3cab8471f9e4dbd370f401b1\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><span>SAMDATA BYYCHARTS</span></p><p><blockquote><p class=\"t-img-caption\"><span>SAMDATA BYYCHARTS</span></p></blockquote></p><p> It's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.</p><p><blockquote>它现在正处于衰退之中，因为它的硬苏打水品牌在雪崩般的竞争中表现不佳。下跌后，该股为投资者提供了一个他们不常得到的机会。分析师仍预计今年营收为21.6亿美元。这使得预计市盈率低于3，接近2019年初以来的最低水平。</blockquote></p><p> Of course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.</p><p><blockquote>当然，在好转之前，情况可能会变得更糟。管理层在7月份大幅下调了盈利预测，然后在本月早些时候撤回了指引，称这将产生与该产品相关的冲销和费用。尽管这很可怕，但我打赌波士顿啤酒将重复其在经济低迷时期幸存下来、找到新趋势并在未来几年创下历史新高的历史。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MKL":"Markel Corp","ADBE":"Adobe","SAM":"波斯顿啤酒","TTWO":"Take-Two Interactive Software","VRTX":"福泰制药"},"source_url":"https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137784790","content_text":"History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.\nI can't tell you where Adobe(NASDAQ:ADBE),Markel(NYSE:MKL),Take Two Interactive Software(NASDAQ:TTWO),Vertex Pharmaceuticals(NASDAQ:VRTX), and BostonBeer(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.\nAdobe\nAt a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.\nDigital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.\nThe business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better thanMicrosoft.\nCEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.\nMarkel\nMarkel has been called the \"baby Berkshire\" for its resemblance to Berkshire Hathaway. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.\nOne big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.\nMKLDATA BYYCHARTS\nAt less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.\nTake Two Interactive\nTake Two has one of the most popular video game franchises of all time --Grand Theft Auto. As of last year, the fifth installment in the series --GTA V-- was the third-best-selling video game ever. It trailed onlyMinecraftandTetris. Want more proof? It tookGTA Vthree days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performingHarry Pottermovie, andAvatar. And the company has more in its stable.\nAnother of its popular games -- theNBA2Kseries -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.\nSince 2012, sales have grown 308%. That compares favorably toActivision Blizzard's 70% andElectronic Arts' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.\nEA REVENUE (ANNUAL)DATA BYYCHARTS\nVertex Pharmaceuticals\nSome drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.\nManagement believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.\nIt has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration withCRISPR Therapeutics-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs withModernaand Arbor Biotechnologies. It's a robust pipeline with a lot of potential.\nDespite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.\nBoston Beer\nRiding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.\nSAMDATA BYYCHARTS\nIt's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.\nOf course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.","news_type":1,"symbols_score_info":{"TTWO":0.9,"SAM":0.9,"ADBE":0.9,"MKL":0.9,"VRTX":0.9}},"isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886543377,"gmtCreate":1631608948599,"gmtModify":1631888993340,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"I was thinking about forgerock considering the valuations, any suggestions on investments","listText":"I was thinking about forgerock considering the valuations, any suggestions on investments","text":"I was thinking about forgerock considering the valuations, any suggestions on investments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/886543377","repostId":"1160275332","repostType":4,"repost":{"id":"1160275332","kind":"news","pubTimestamp":1631604098,"share":"https://www.laohu8.com/m/news/1160275332?lang=zh_CN&edition=full","pubTime":"2021-09-14 15:21","market":"us","language":"en","title":"Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160275332","media":"MarketWatch","summary":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit th","content":"<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p><p><blockquote>罗杰·费德勒支持的瑞士跑鞋公司和得来速咖啡连锁店预计将于本周上市</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p><p><blockquote><p class=\"t-img-caption\"><span>瑞士网球巨头罗杰·费德勒是本周最大IPO之一的支持者。</span></p></blockquote></p><p> After a flurry of initial-public-offering launches last week&nbsp;set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p><p><blockquote>上周一系列首次公开募股引发市场交易繁忙，预计本周将有11家公司定价，筹集超过30亿美元的资金。</blockquote></p><p> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p><p><blockquote>机构研究和交易所交易基金提供商Renaissance Capital创始人兼首席执行官比尔·史密斯(Bill Smith)表示，如果所有交易都实现，2021年将成为有史以来IPO收益最大的一年，并将之前的记录打破约30%。以IPO为导向的基金。据Renaissance称，预计今年市场将出现约375笔交易，筹集1250亿美元，超过2000年互联网繁荣期间筹集的970亿美元。</blockquote></p><p> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p><p><blockquote>史密斯在市场评论中写道：“在漫长的暑假之后，本周是即将到来的科技、生物技术和消费者IPO的试金石。”该名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家得来速咖啡亭运营商以及一家从保险公司Genworth Financial分拆出来的抵押贷款保险公司。</blockquote></p><p> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p><p><blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司Thoughtworks，该公司将以高达61亿美元的估值上市。</blockquote></p><p> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p><p><blockquote>该公司预计在IPO完成后将更名从Turing Holding Corp.更名为Thoughtworks，并表示将发行总计3684万股股票，由公司和出售股东分配。</blockquote></p><p> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p><p><blockquote>该交易预计定价在每股18美元至20美元之间，该股将在纳斯达克交易，股票代码为“TWKS”。高盛和摩根大通是主承销商。该公司2020年净利润为7930万美元，营收为8.034亿美元，2019年营收为7.722亿美元，营收为2840万美元。</blockquote></p><p> The Swiss athletic-footwear maker On Holding&nbsp;is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p><p><blockquote>这家持有股份的瑞士运动鞋制造商预计将以近60亿美元的估值筹集至多6.22亿美元。On已申请在纽约证券交易所上市3110万股，每股价格为18至20美元，股票代码为“ONON”。</blockquote></p><p> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p><p><blockquote>高盛、摩根士丹利和摩根士丹利是此次交易的九家银行组成的银团的主承销商。收益将用于一般公司用途。该公司有一条与费德勒共同开发的生产线。</blockquote></p><p> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period,&nbsp;according to its IPO documents.&nbsp;Sales came to 315.5 million francs, up from 170.9 million francs.</p><p><blockquote>根据其IPO文件，在截至6月30日的六个月中，该公司的净利润为380万瑞士法郎（合410万美元），而上年同期为亏损3310万瑞士法郎，而去年同期的销售额为3.155亿瑞士法郎，高于1.709亿瑞士法郎。</blockquote></p><p> Also from Switzerland, sports betting site Sportrader Group AG&nbsp;plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p><p><blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划以每股25至28美元的价格发行1900万股股票，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为“SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的13家银行组成的银团的主承销商。</blockquote></p><p> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million,&nbsp;according to its filing documents.</p><p><blockquote>收益将用于营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为2990万美元，营收为3.21亿美元。</blockquote></p><p> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p><p><blockquote>Dutch Bros Inc.是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在IPO中发行2110万股股票，每股价格为18至20美元，公司估值高达33亿美元。</blockquote></p><p> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p><p><blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的13家银行组成的财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为“BROS”。</blockquote></p><p> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p><p><blockquote>所得款项将用于购买额外的A类股票——该公司计划拥有四类具有不同投票权的股票。该公司今年前六个月的净亏损为1,360万美元，即每股亏损32美分，低于去年同期的1,650万美元，即每股亏损38美分。收入从3.274亿美元降至2.279亿美元。</blockquote></p><p> <b>Rounding out the list are:</b></p><p><blockquote><b>名单上还有：</b></blockquote></p><p> •&nbsp;Definitive Healthcare Corp.,&nbsp;a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p><p><blockquote>•总部位于马萨诸塞州的医疗保健商业情报提供商Definitive Healthcare Corp.计划在其PO中发行1556万股股票，预计定价在每股21美元至24美元之间。按照这个定价，该公司的估值可能高达35.5亿美元。</blockquote></p><p></p><p> •&nbsp;Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p><p><blockquote>Genworth旗下的抵押贷款保险公司Enact Holdings Inc.计划发行1330万股股票，每股价格为19至20美元。该公司的估值为33亿美元，处于该范围的顶部。该公司表示，Genworth将出售所有股份，不会获得任何收益。它已申请在纳斯达克上市，股票代码为“ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote></p><p> •&nbsp;ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>&nbsp;a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p><p><blockquote>•锻造岩石<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>一家总部位于加州的身份安全平台希望通过发行1100万股股票，每股价格在21美元至24美元之间，筹集至多2.64亿美元。该定价将使该公司估值高达19.1亿美元。</blockquote></p><p> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p><p><blockquote>该股预计将在纽约证券交易所上市，股票代码为“FORG”。摩根士丹利和摩根大通是主承销商。该公司在2020年录得净亏损4180万美元，营收为1.276亿美元，而2019年营收为1.045亿美元，亏损3690万美元。</blockquote></p><p> <b>•</b>Dice Therapeutics&nbsp;is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p><p><blockquote><b>•</b>Dice Therapeutics预计将以高达5.83亿美元的估值筹集至多1.7亿美元，并在纳斯达克上市，股票代码为“DICE”。该生物技术公司正在免疫学领域开发治疗慢性疾病的疗法。</blockquote></p><p> <b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p><p><blockquote><b>•</b>手术机器人开发商Procept BioRobotics计划以约10亿美元的估值筹集至多1.32亿美元，并计划在纳斯达克上市，股票代码为“PRCT”。美银证券和高盛是主承销商。</blockquote></p><p> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p><p><blockquote>该公司在其IPO文件中表示：“我们开发、制造和销售AquaBeam机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初重点是治疗良性前列腺增生（BPH）。”</blockquote></p><p> <b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p><p><blockquote><b>•</b>Tyra Biosciences的目标是通过IPO筹集1.072亿美元，估值为5.89亿美元。该生物技术公司的领先候选产品是膀胱癌的治疗方法。它已申请在纳斯达克上市，股票代码为“TYRA”。</blockquote></p><p> <b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p><p><blockquote><b>•</b>EzFill Holdings是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以1亿美元的估值筹集2500万美元。该公司已申请在纳斯达克上市，股票代码为“EZFL”。ThinkEquity是独家承销商。</blockquote></p><p> The Renaissance IPO ETF&nbsp;has gained 6% to date in 2021, while the S&amp;P 500&nbsp;has advanced 19%.</p><p><blockquote>2021年迄今为止，Renaissance IPO ETF已上涨6%，而标普500则上涨19%。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBusy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-09-14 15:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p><p><blockquote>罗杰·费德勒支持的瑞士跑鞋公司和得来速咖啡连锁店预计将于本周上市</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p><p><blockquote><p class=\"t-img-caption\"><span>瑞士网球巨头罗杰·费德勒是本周最大IPO之一的支持者。</span></p></blockquote></p><p> After a flurry of initial-public-offering launches last week&nbsp;set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p><p><blockquote>上周一系列首次公开募股引发市场交易繁忙，预计本周将有11家公司定价，筹集超过30亿美元的资金。</blockquote></p><p> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p><p><blockquote>机构研究和交易所交易基金提供商Renaissance Capital创始人兼首席执行官比尔·史密斯(Bill Smith)表示，如果所有交易都实现，2021年将成为有史以来IPO收益最大的一年，并将之前的记录打破约30%。以IPO为导向的基金。据Renaissance称，预计今年市场将出现约375笔交易，筹集1250亿美元，超过2000年互联网繁荣期间筹集的970亿美元。</blockquote></p><p> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p><p><blockquote>史密斯在市场评论中写道：“在漫长的暑假之后，本周是即将到来的科技、生物技术和消费者IPO的试金石。”该名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家得来速咖啡亭运营商以及一家从保险公司Genworth Financial分拆出来的抵押贷款保险公司。</blockquote></p><p> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p><p><blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司Thoughtworks，该公司将以高达61亿美元的估值上市。</blockquote></p><p> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p><p><blockquote>该公司预计在IPO完成后将更名从Turing Holding Corp.更名为Thoughtworks，并表示将发行总计3684万股股票，由公司和出售股东分配。</blockquote></p><p> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p><p><blockquote>该交易预计定价在每股18美元至20美元之间，该股将在纳斯达克交易，股票代码为“TWKS”。高盛和摩根大通是主承销商。该公司2020年净利润为7930万美元，营收为8.034亿美元，2019年营收为7.722亿美元，营收为2840万美元。</blockquote></p><p> The Swiss athletic-footwear maker On Holding&nbsp;is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p><p><blockquote>这家持有股份的瑞士运动鞋制造商预计将以近60亿美元的估值筹集至多6.22亿美元。On已申请在纽约证券交易所上市3110万股，每股价格为18至20美元，股票代码为“ONON”。</blockquote></p><p> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p><p><blockquote>高盛、摩根士丹利和摩根士丹利是此次交易的九家银行组成的银团的主承销商。收益将用于一般公司用途。该公司有一条与费德勒共同开发的生产线。</blockquote></p><p> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period,&nbsp;according to its IPO documents.&nbsp;Sales came to 315.5 million francs, up from 170.9 million francs.</p><p><blockquote>根据其IPO文件，在截至6月30日的六个月中，该公司的净利润为380万瑞士法郎（合410万美元），而上年同期为亏损3310万瑞士法郎，而去年同期的销售额为3.155亿瑞士法郎，高于1.709亿瑞士法郎。</blockquote></p><p> Also from Switzerland, sports betting site Sportrader Group AG&nbsp;plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p><p><blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划以每股25至28美元的价格发行1900万股股票，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为“SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的13家银行组成的银团的主承销商。</blockquote></p><p> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million,&nbsp;according to its filing documents.</p><p><blockquote>收益将用于营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为2990万美元，营收为3.21亿美元。</blockquote></p><p> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p><p><blockquote>Dutch Bros Inc.是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在IPO中发行2110万股股票，每股价格为18至20美元，公司估值高达33亿美元。</blockquote></p><p> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p><p><blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的13家银行组成的财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为“BROS”。</blockquote></p><p> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p><p><blockquote>所得款项将用于购买额外的A类股票——该公司计划拥有四类具有不同投票权的股票。该公司今年前六个月的净亏损为1,360万美元，即每股亏损32美分，低于去年同期的1,650万美元，即每股亏损38美分。收入从3.274亿美元降至2.279亿美元。</blockquote></p><p> <b>Rounding out the list are:</b></p><p><blockquote><b>名单上还有：</b></blockquote></p><p> •&nbsp;Definitive Healthcare Corp.,&nbsp;a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p><p><blockquote>•总部位于马萨诸塞州的医疗保健商业情报提供商Definitive Healthcare Corp.计划在其PO中发行1556万股股票，预计定价在每股21美元至24美元之间。按照这个定价，该公司的估值可能高达35.5亿美元。</blockquote></p><p></p><p> •&nbsp;Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p><p><blockquote>Genworth旗下的抵押贷款保险公司Enact Holdings Inc.计划发行1330万股股票，每股价格为19至20美元。该公司的估值为33亿美元，处于该范围的顶部。该公司表示，Genworth将出售所有股份，不会获得任何收益。它已申请在纳斯达克上市，股票代码为“ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote></p><p> •&nbsp;ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>&nbsp;a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p><p><blockquote>•锻造岩石<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>一家总部位于加州的身份安全平台希望通过发行1100万股股票，每股价格在21美元至24美元之间，筹集至多2.64亿美元。该定价将使该公司估值高达19.1亿美元。</blockquote></p><p> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p><p><blockquote>该股预计将在纽约证券交易所上市，股票代码为“FORG”。摩根士丹利和摩根大通是主承销商。该公司在2020年录得净亏损4180万美元，营收为1.276亿美元，而2019年营收为1.045亿美元，亏损3690万美元。</blockquote></p><p> <b>•</b>Dice Therapeutics&nbsp;is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p><p><blockquote><b>•</b>Dice Therapeutics预计将以高达5.83亿美元的估值筹集至多1.7亿美元，并在纳斯达克上市，股票代码为“DICE”。该生物技术公司正在免疫学领域开发治疗慢性疾病的疗法。</blockquote></p><p> <b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p><p><blockquote><b>•</b>手术机器人开发商Procept BioRobotics计划以约10亿美元的估值筹集至多1.32亿美元，并计划在纳斯达克上市，股票代码为“PRCT”。美银证券和高盛是主承销商。</blockquote></p><p> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p><p><blockquote>该公司在其IPO文件中表示：“我们开发、制造和销售AquaBeam机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初重点是治疗良性前列腺增生（BPH）。”</blockquote></p><p> <b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p><p><blockquote><b>•</b>Tyra Biosciences的目标是通过IPO筹集1.072亿美元，估值为5.89亿美元。该生物技术公司的领先候选产品是膀胱癌的治疗方法。它已申请在纳斯达克上市，股票代码为“TYRA”。</blockquote></p><p> <b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p><p><blockquote><b>•</b>EzFill Holdings是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以1亿美元的估值筹集2500万美元。该公司已申请在纳斯达克上市，股票代码为“EZFL”。ThinkEquity是独家承销商。</blockquote></p><p> The Renaissance IPO ETF&nbsp;has gained 6% to date in 2021, while the S&amp;P 500&nbsp;has advanced 19%.</p><p><blockquote>2021年迄今为止，Renaissance IPO ETF已上涨6%，而标普500则上涨19%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ONON":"On Holding AG","DRNA":"Dicerna Pharmaceuticals, Inc.",".DJI":"道琼斯","DH":"Definitive Healthcare Corp.","PRCT":"PROCEPT BioRobotics","TYRA":"Tyra Biosciences, Inc.",".IXIC":"NASDAQ Composite","SRAD":"Sportradar Group AG",".SPX":"S&P 500 Index","BROS":"Dutch Bros Inc.","FORG":"ForgeRock, Inc.","TWKS":"Thoughtworks Holding Inc."},"source_url":"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160275332","content_text":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week \nSwiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.\n\n\nAfter a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. \n\nIf all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. \n\n“After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. \n\nThe biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.\nThe company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.\n\nThe deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.\nThe Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”\n\nGoldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.\n\nThe company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.\n\nAlso from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.\n\nProceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.\n\nDutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.\n\nBofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”\nProceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.\n\nRounding out the list are:\n• Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.\n• Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.\n• ForgeRock, a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.\nThe stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.\n•Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.\n•Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.\n“We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.\n•Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”\n•EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.\nThe Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.","news_type":1,"symbols_score_info":{"TYRA":0.9,".IXIC":0.9,"DRNA":0.9,"ONON":0.9,"FORG":0.9,"SRAD":0.9,".SPX":0.9,"TWKS":0.9,"BROS":0.9,"DH":0.9,".DJI":0.9,"ACT.UK":0.9,"PRCT":0.9}},"isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883739398,"gmtCreate":1631271667914,"gmtModify":1631888993343,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Will consider","listText":"Will consider","text":"Will consider","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883739398","repostId":"2166897344","repostType":4,"isVote":1,"tweetType":1,"viewCount":534,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812593303,"gmtCreate":1630593253402,"gmtModify":1631888993344,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"😂 we can only dream, if that happens I will increase my apple&nbsp;portfolio size to 25%😂","listText":"😂 we can only dream, if that happens I will increase my apple&nbsp;portfolio size to 25%😂","text":"😂 we can only dream, if that happens I will increase my apple portfolio size to 25%😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812593303","repostId":"1131318558","repostType":4,"repost":{"id":"1131318558","kind":"news","pubTimestamp":1630591645,"share":"https://www.laohu8.com/m/news/1131318558?lang=zh_CN&edition=full","pubTime":"2021-09-02 22:07","market":"us","language":"en","title":"Bear Attack: Could Apple Stock Really Drop 40%?<blockquote>空头攻击：苹果股价真的会下跌40%吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1131318558","media":"Thestreet","summary":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?On the first day of September, one of the rare Wall Street bears on Apple stock  finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall ","content":"<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?</p><p><blockquote>对苹果股票给予卖出评级的两位华尔街分析师之一认输了。另一位仍然认为AAPL股价可能会下跌40%。巨大的下行风险现实吗？</blockquote></p><p> On the first day of September, one of the rare Wall Street bears on Apple stock&nbsp;(<b>AAPL</b>)&nbsp;finally gave in and dropped his sell rating. The last remaining one still&nbsp;sees&nbsp;shares dropping to a price target of $90, representing risk of loss of around 40%.</p><p><blockquote>九月的第一天，华尔街罕见的看空苹果股票之一（<b>AAPL</b>）最终让步，下调了卖出评级。剩下的最后一位仍将股价跌至90美元的目标价，损失风险约为40%。</blockquote></p><p> Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.</p><p><blockquote>New Street的Pierre Ferragu是华尔街最后一位看空苹果的人，他对看涨期权下行的看法可能是正确的吗？这位苹果专家更仔细地观察了这场争论。</blockquote></p><p> <b>Why bearish on Apple?</b></p><p><blockquote><b>为什么看空苹果？</b></blockquote></p><p> The core of Pierre’s bearish argument&nbsp;seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.</p><p><blockquote>Pierre看空论点的核心似乎是iPhone。这位分析师将即将推出的设备称为“12S周期”，认为苹果iPhone升级浪潮中最好的部分，即所谓的5G超级周期，已经成为过去。</blockquote></p><p> New Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the&nbsp;opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:</p><p><blockquote>New Street赞同这样的观点，即强劲的iPhone 12周期拉动了智能手机销量，导致未来需求出现缺口。有趣的是，这与看涨的Wedbush分析师Dan Ives的观点完全相反，Dan Ives在接受《苹果专家》采访时表示：</blockquote></p><p>   “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”  Still on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.</p><p><blockquote>“华尔街低估了这个超级周期的规模和长度。[……]在网络建成之前，5G在未来两三年内不会被完全接受。在中国（5G基础设施更加领先），iPhone 12，尤其是较大的Pro版本，确实卖得非常好。”Ferragu先生仍然在iPhone上，早在4月份就提出了他对2022年的预期（我不知道此后有任何修改）。他认为iPhone出货量将达到1.9亿部，这意味着该部门的收入约为1500亿美元——比COVID-19水平每年小幅增长5%。</blockquote></p><p> <b>Could AAPL sink 40%?</b></p><p><blockquote><b>AAPL会下跌40%吗？</b></blockquote></p><p> Now, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).</p><p><blockquote>现在，让我们动笔。苹果股票的估值要达到每股90美元，需要发生两件事之一：要么财务业绩需要落后于普遍预期，要么估值需要收缩（或两者兼而有之）。</blockquote></p><p> On results,Wall Street currently sees&nbsp;fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.</p><p><blockquote>从业绩来看，华尔街目前预计2022财年每股收益将达到5.63美元，与迄今为止令人印象深刻的2021财年基本持平。因此，苹果公司要想股价下跌40%，明年的盈利就需要大幅低于市场预期，至少下降几美元。我觉得这不太可能。</blockquote></p><p> On valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.</p><p><blockquote>从估值来看，AAPL目前的2021财年市盈率为27倍。假设未来的结果与共识匹配，这一市盈率需要降至16倍左右，AAPL股价才能跌至90美元。该股的预期市盈率多年来从未如此低。</blockquote></p><p> <b>The Apple Maven’s take</b></p><p><blockquote><b>苹果专家的看法</b></blockquote></p><p> I find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.</p><p><blockquote>我发现苹果的估值即使不是几乎不可能，也不太可能再次达到每股90美元。在我看来，更合理的是，在AAPL在过去六个月内上涨了25%之后，New Street目前的股价目标已经过时了。</blockquote></p><p> Therefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.</p><p><blockquote>因此，看到华尔街最后一次看空苹果公司最终（很快？）屈服于他的下行信念，至少在与他当前的价格目标相关的方面，我不会感到惊讶。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bear Attack: Could Apple Stock Really Drop 40%?<blockquote>空头攻击：苹果股价真的会下跌40%吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBear Attack: Could Apple Stock Really Drop 40%?<blockquote>空头攻击：苹果股价真的会下跌40%吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Thestreet</strong><span class=\"h-time small\">2021-09-02 22:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?</p><p><blockquote>对苹果股票给予卖出评级的两位华尔街分析师之一认输了。另一位仍然认为AAPL股价可能会下跌40%。巨大的下行风险现实吗？</blockquote></p><p> On the first day of September, one of the rare Wall Street bears on Apple stock&nbsp;(<b>AAPL</b>)&nbsp;finally gave in and dropped his sell rating. The last remaining one still&nbsp;sees&nbsp;shares dropping to a price target of $90, representing risk of loss of around 40%.</p><p><blockquote>九月的第一天，华尔街罕见的看空苹果股票之一（<b>AAPL</b>）最终让步，下调了卖出评级。剩下的最后一位仍将股价跌至90美元的目标价，损失风险约为40%。</blockquote></p><p> Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.</p><p><blockquote>New Street的Pierre Ferragu是华尔街最后一位看空苹果的人，他对看涨期权下行的看法可能是正确的吗？这位苹果专家更仔细地观察了这场争论。</blockquote></p><p> <b>Why bearish on Apple?</b></p><p><blockquote><b>为什么看空苹果？</b></blockquote></p><p> The core of Pierre’s bearish argument&nbsp;seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.</p><p><blockquote>Pierre看空论点的核心似乎是iPhone。这位分析师将即将推出的设备称为“12S周期”，认为苹果iPhone升级浪潮中最好的部分，即所谓的5G超级周期，已经成为过去。</blockquote></p><p> New Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the&nbsp;opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:</p><p><blockquote>New Street赞同这样的观点，即强劲的iPhone 12周期拉动了智能手机销量，导致未来需求出现缺口。有趣的是，这与看涨的Wedbush分析师Dan Ives的观点完全相反，Dan Ives在接受《苹果专家》采访时表示：</blockquote></p><p>   “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”  Still on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.</p><p><blockquote>“华尔街低估了这个超级周期的规模和长度。[……]在网络建成之前，5G在未来两三年内不会被完全接受。在中国（5G基础设施更加领先），iPhone 12，尤其是较大的Pro版本，确实卖得非常好。”Ferragu先生仍然在iPhone上，早在4月份就提出了他对2022年的预期（我不知道此后有任何修改）。他认为iPhone出货量将达到1.9亿部，这意味着该部门的收入约为1500亿美元——比COVID-19水平每年小幅增长5%。</blockquote></p><p> <b>Could AAPL sink 40%?</b></p><p><blockquote><b>AAPL会下跌40%吗？</b></blockquote></p><p> Now, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).</p><p><blockquote>现在，让我们动笔。苹果股票的估值要达到每股90美元，需要发生两件事之一：要么财务业绩需要落后于普遍预期，要么估值需要收缩（或两者兼而有之）。</blockquote></p><p> On results,Wall Street currently sees&nbsp;fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.</p><p><blockquote>从业绩来看，华尔街目前预计2022财年每股收益将达到5.63美元，与迄今为止令人印象深刻的2021财年基本持平。因此，苹果公司要想股价下跌40%，明年的盈利就需要大幅低于市场预期，至少下降几美元。我觉得这不太可能。</blockquote></p><p> On valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.</p><p><blockquote>从估值来看，AAPL目前的2021财年市盈率为27倍。假设未来的结果与共识匹配，这一市盈率需要降至16倍左右，AAPL股价才能跌至90美元。该股的预期市盈率多年来从未如此低。</blockquote></p><p> <b>The Apple Maven’s take</b></p><p><blockquote><b>苹果专家的看法</b></blockquote></p><p> I find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.</p><p><blockquote>我发现苹果的估值即使不是几乎不可能，也不太可能再次达到每股90美元。在我看来，更合理的是，在AAPL在过去六个月内上涨了25%之后，New Street目前的股价目标已经过时了。</blockquote></p><p> Therefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.</p><p><blockquote>因此，看到华尔街最后一次看空苹果公司最终（很快？）屈服于他的下行信念，至少在与他当前的价格目标相关的方面，我不会感到惊讶。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40\">Thestreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131318558","content_text":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?\nOn the first day of September, one of the rare Wall Street bears on Apple stock (AAPL) finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.\nCould New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.\nWhy bearish on Apple?\nThe core of Pierre’s bearish argument seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.\nNew Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:\n\n “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”\n\nStill on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.\nCould AAPL sink 40%?\nNow, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).\nOn results,Wall Street currently sees fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.\nOn valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.\nThe Apple Maven’s take\nI find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.\nTherefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812051448,"gmtCreate":1630542774584,"gmtModify":1631888993347,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"I scooped in few during the dip.","listText":"I scooped in few during the dip.","text":"I scooped in few during the dip.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/812051448","repostId":"1191563735","repostType":4,"repost":{"id":"1191563735","kind":"news","pubTimestamp":1630542500,"share":"https://www.laohu8.com/m/news/1191563735?lang=zh_CN&edition=full","pubTime":"2021-09-02 08:28","market":"us","language":"en","title":"Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191563735","media":"Motley Fool","summary":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions ","content":"<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>在美国食品和药物管理局决定要求其关节炎治疗药物Rinvoq的标签上出现心脏风险警告后，（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌7.8%。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据例行审查的一部分，FDA周三宣布，所有在美国被批准用于关节炎治疗的骏利激酶（JAK）抑制剂现在都将在销售时贴有标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA的决定植根于辉瑞关节炎药物Xeljanz的数据。这两种药物是围绕相同的JAK抑制方法构建的，在后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>下意识的反应是可以理解的。虽然艾伯维(AbbVie)以其关节炎、斑块型银屑病和克罗恩病治疗药物Humira而闻名，但Rinvoq是希望帮助弥补因Humira专利到期而造成的销售损失的制药特许经营权之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前情况而言，Rinvoq仅占艾伯维收入的不到3%，其潜力仍不清楚。这家制药巨头的产品组合中仍有二十多种药物——其中许多已经是比Rinvoq更大的特许经营权——甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-02 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>在美国食品和药物管理局决定要求其关节炎治疗药物Rinvoq的标签上出现心脏风险警告后，（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌7.8%。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据例行审查的一部分，FDA周三宣布，所有在美国被批准用于关节炎治疗的骏利激酶（JAK）抑制剂现在都将在销售时贴有标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA的决定植根于辉瑞关节炎药物Xeljanz的数据。这两种药物是围绕相同的JAK抑制方法构建的，在后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>下意识的反应是可以理解的。虽然艾伯维(AbbVie)以其关节炎、斑块型银屑病和克罗恩病治疗药物Humira而闻名，但Rinvoq是希望帮助弥补因Humira专利到期而造成的销售损失的制药特许经营权之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前情况而言，Rinvoq仅占艾伯维收入的不到3%，其潜力仍不清楚。这家制药巨头的产品组合中仍有二十多种药物——其中许多已经是比Rinvoq更大的特许经营权——甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191563735","content_text":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.\n\nWhat happened\nShares of drugmakerAbbVie(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.\nSo what\nAs part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.\nBlamePfizer(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.\nNow what\nThe knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.\nAs it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.","news_type":1,"symbols_score_info":{"ABBV":0.9}},"isVote":1,"tweetType":1,"viewCount":858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816040756,"gmtCreate":1630457373075,"gmtModify":1631888993352,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"Will add more once it gets a support.. I believe inthe management.","listText":"Will add more once it gets a support.. I believe inthe management.","text":"Will add more once it gets a support.. I believe inthe management.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/816040756","repostId":"1140744418","repostType":4,"isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819137040,"gmtCreate":1630042697380,"gmtModify":1704955073874,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","listText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","text":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/819137040","repostId":"2162090400","repostType":4,"isVote":1,"tweetType":1,"viewCount":670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810686066,"gmtCreate":1629971819655,"gmtModify":1631888993359,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"I was thinking of buying, now I will back off 😞","listText":"I was thinking of buying, now I will back off 😞","text":"I was thinking of buying, now I will back off 😞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810686066","repostId":"1113528238","repostType":4,"isVote":1,"tweetType":1,"viewCount":520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896478321,"gmtCreate":1628603527063,"gmtModify":1631888993363,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582610336531043","idStr":"3582610336531043"},"themes":[],"htmlText":"To the moon 🚀&nbsp;","listText":"To the moon 🚀&nbsp;","text":"To the moon 🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896478321","repostId":"1181860181","repostType":4,"repost":{"id":"1181860181","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628603123,"share":"https://www.laohu8.com/m/news/1181860181?lang=zh_CN&edition=full","pubTime":"2021-08-10 21:45","market":"us","language":"en","title":"Novavax shares jumped nearly 12% in early trading.<blockquote>Novavax股价早盘上涨近12%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181860181","media":"Tiger Newspress","summary":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the th","content":"<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p><p><blockquote>Novavax股价早盘上涨近12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p><p><blockquote>据《巴伦周刊》报道，美国第三大公共养老金机构纽约州共同退休基金增加了对Novavax股票的投资。</blockquote></p><p> The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p><p><blockquote>该养老金还将其对COVID-19疫苗公司Moderna Inc.的投资增加了一倍。</blockquote></p><p> The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p><p><blockquote>该退休基金还在辉瑞公司的德国COVID-19疫苗合作伙伴BioNTech SE设立了一个职位。</blockquote></p><p> Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p><p><blockquote>据《马尼拉公报》报道，同样在周一，菲律宾食品和药物管理局开始评估Novavax的COVID-19疫苗紧急使用授权申请。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped nearly 12% in early trading.<blockquote>Novavax股价早盘上涨近12%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped nearly 12% in early trading.<blockquote>Novavax股价早盘上涨近12%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-10 21:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p><p><blockquote>Novavax股价早盘上涨近12%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p><p><blockquote>据《巴伦周刊》报道，美国第三大公共养老金机构纽约州共同退休基金增加了对Novavax股票的投资。</blockquote></p><p> The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p><p><blockquote>该养老金还将其对COVID-19疫苗公司Moderna Inc.的投资增加了一倍。</blockquote></p><p> The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p><p><blockquote>该退休基金还在辉瑞公司的德国COVID-19疫苗合作伙伴BioNTech SE设立了一个职位。</blockquote></p><p> Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p><p><blockquote>据《马尼拉公报》报道，同样在周一，菲律宾食品和药物管理局开始评估Novavax的COVID-19疫苗紧急使用授权申请。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181860181","content_text":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported Barron's.\nThe pension also doubled its investment in COVID-19 vaccine play Moderna Inc .\nThe retirement fund also initiated a position in BioNTech SE , the German COVID-19 vaccine partner of Pfizer Inc.\nAlso on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":717,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":812051448,"gmtCreate":1630542774584,"gmtModify":1631888993347,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"I scooped in few during the dip.","listText":"I scooped in few during the dip.","text":"I scooped in few during the dip.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/812051448","repostId":"1191563735","repostType":4,"repost":{"id":"1191563735","kind":"news","pubTimestamp":1630542500,"share":"https://www.laohu8.com/m/news/1191563735?lang=zh_CN&edition=full","pubTime":"2021-09-02 08:28","market":"us","language":"en","title":"Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1191563735","media":"Motley Fool","summary":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions ","content":"<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>在美国食品和药物管理局决定要求其关节炎治疗药物Rinvoq的标签上出现心脏风险警告后，（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌7.8%。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据例行审查的一部分，FDA周三宣布，所有在美国被批准用于关节炎治疗的骏利激酶（JAK）抑制剂现在都将在销售时贴有标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA的决定植根于辉瑞关节炎药物Xeljanz的数据。这两种药物是围绕相同的JAK抑制方法构建的，在后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>下意识的反应是可以理解的。虽然艾伯维(AbbVie)以其关节炎、斑块型银屑病和克罗恩病治疗药物Humira而闻名，但Rinvoq是希望帮助弥补因Humira专利到期而造成的销售损失的制药特许经营权之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前情况而言，Rinvoq仅占艾伯维收入的不到3%，其潜力仍不清楚。这家制药巨头的产品组合中仍有二十多种药物——其中许多已经是比Rinvoq更大的特许经营权——甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AbbVie Is Down More Than 7% Wednesday<blockquote>为什么艾伯维周三下跌超过7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-02 08:28</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.  <b>What happened</b></p><p><blockquote>食品药品监督管理局正在得出合理的结论，但不一定是对消费者非常重要的结论。<b>发生了什么</b></blockquote></p><p> Shares of drugmaker<b>AbbVie</b>(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.</p><p><blockquote>制药商股份<b>艾伯维</b>在美国食品和药物管理局决定要求其关节炎治疗药物Rinvoq的标签上出现心脏风险警告后，（纽约证券交易所股票代码：ABBV）在周三下午的交易时段下跌7.8%。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> As part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.</p><p><blockquote>作为临床试验数据例行审查的一部分，FDA周三宣布，所有在美国被批准用于关节炎治疗的骏利激酶（JAK）抑制剂现在都将在销售时贴有标签，警告其使用者此类药物会增加严重心脏相关事件、癌症、血栓甚至死亡的风险。艾伯维的Rinvoq就是这些抑制JAK的处方药之一。</blockquote></p><p> Blame<b>Pfizer</b>(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.</p><p><blockquote>责怪<b>辉瑞</b>然而（纽约证券交易所股票代码：PFE）。FDA的决定植根于辉瑞关节炎药物Xeljanz的数据。这两种药物是围绕相同的JAK抑制方法构建的，在后期测试中，它被证明会增加血栓和相关心脏问题的风险。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> The knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.</p><p><blockquote>下意识的反应是可以理解的。虽然艾伯维(AbbVie)以其关节炎、斑块型银屑病和克罗恩病治疗药物Humira而闻名，但Rinvoq是希望帮助弥补因Humira专利到期而造成的销售损失的制药特许经营权之一。</blockquote></p><p> As it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.</p><p><blockquote>但就目前情况而言，Rinvoq仅占艾伯维收入的不到3%，其潜力仍不清楚。这家制药巨头的产品组合中仍有二十多种药物——其中许多已经是比Rinvoq更大的特许经营权——甚至还有更多药物正在研发中。也没有任何迹象表明关节炎患者会仅仅因为标签警告而放弃或避免使用该药物。一旦投资者克服了周三消息的最初冲击，对于已经关注该股的投资者来说，抛售很容易成为买入机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/09/01/why-abbvie-is-down-more-than-7-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191563735","content_text":"The Food and Drug Administration is drawing reasonable conclusions, but not necessarily conclusions that matter much to consumers.\n\nWhat happened\nShares of drugmakerAbbVie(NYSE:ABBV)are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk warning on the label of its arthritis treatment Rinvoq.\nSo what\nAs part of its routine reviews of clinical trial data, the FDA announced Wednesday that all Janus kinase (JAK) inhibitors approved for use as arthritis treatments in the United States are now to be sold with a label cautioning their users that such drugs raise the risk of serious heart-related events, cancer, blood clots, and even death. AbbVie's Rinvoq is one of these JAK-inhibiting prescription drugs.\nBlamePfizer(NYSE:PFE), however. The FDA's decision was rooted in data regarding Pfizer's arthritis medicine Xeljanz. The two drugs in question are built around the same JAK-inhibiting approach, and in its later-stage testing it was shown to increase the risk of blood clots and related heart problems.\nNow what\nThe knee-jerk reaction is understandable. While AbbVie is best known for its arthritis, plaque psoriasis, and Crohn's disease treatment Humira, Rinvoq was one of thepharmaceuticalfranchises hoped to help replace the loss of sales linked to the expiration of Humira's patents.\nAs it stands right now though, Rinvoq accounts for less than 3% of AbbVie's revenue, and its potential was still unclear. The pharmaceutical giant also still has more than two dozen drugs in its portfolio -- many of which are already bigger franchises than Rinvoq -- and even more in the research and development pipeline. There's also nothing to firmly suggest arthritic patients will abandon or avoid the drug simply because of the label warning. Once investors work through the initial shock of Wednesday's news, the sell-off could readily become a buying opportunity for investors already eyeing the stock.","news_type":1,"symbols_score_info":{"ABBV":0.9}},"isVote":1,"tweetType":1,"viewCount":858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":809227876,"gmtCreate":1627374050595,"gmtModify":1631891947218,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Will add more JD and NIO","listText":"Will add more JD and NIO","text":"Will add more JD and NIO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/809227876","repostId":"1142907091","repostType":4,"repost":{"id":"1142907091","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627373467,"share":"https://www.laohu8.com/m/news/1142907091?lang=zh_CN&edition=full","pubTime":"2021-07-27 16:11","market":"us","language":"en","title":"Hot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中概股盘前恢复下行</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142907091","media":"Tiger Newspress","summary":"Hot Chinese concept stocks resumed downward in premarket trading.Bilibili and NetEase fell 7%,DiDi G","content":"<p>Hot Chinese concept stocks resumed downward&nbsp;in premarket trading.Bilibili&nbsp;and&nbsp;NetEase&nbsp;fell&nbsp;7%,DiDi Global,JD.com&nbsp;and&nbsp;Pinduoduo&nbsp;fell&nbsp;6%,Baidu&nbsp;fell&nbsp;5%,Xpeng Motors&nbsp;fell&nbsp;4%,Alibaba,Nio&nbsp;and Li Auto&nbsp;fell&nbsp;3%.</p><p><blockquote>热点中概股盘前恢复下行，哔哩哔哩、网易跌7%，滴滴全球、京东、拼多多跌6%，百度跌5%，小鹏汽车跌4%，阿里巴巴-SW、蔚来、理想汽车跌3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6d3f423af5595483b1ce34aa42d60cc7\" tg-width=\"355\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中概股盘前恢复下行</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot Chinese concept stocks resumed downward in premarket trading<blockquote>热门中概股盘前恢复下行</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-27 16:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hot Chinese concept stocks resumed downward&nbsp;in premarket trading.Bilibili&nbsp;and&nbsp;NetEase&nbsp;fell&nbsp;7%,DiDi Global,JD.com&nbsp;and&nbsp;Pinduoduo&nbsp;fell&nbsp;6%,Baidu&nbsp;fell&nbsp;5%,Xpeng Motors&nbsp;fell&nbsp;4%,Alibaba,Nio&nbsp;and Li Auto&nbsp;fell&nbsp;3%.</p><p><blockquote>热点中概股盘前恢复下行，哔哩哔哩、网易跌7%，滴滴全球、京东、拼多多跌6%，百度跌5%，小鹏汽车跌4%，阿里巴巴-SW、蔚来、理想汽车跌3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6d3f423af5595483b1ce34aa42d60cc7\" tg-width=\"355\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度","JD":"京东","LI":"理想汽车","DIDI":"滴滴(已退市)","BABA":"阿里巴巴","PDD":"拼多多","NIO":"蔚来","XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142907091","content_text":"Hot Chinese concept stocks resumed downward in premarket trading.Bilibili and NetEase fell 7%,DiDi Global,JD.com and Pinduoduo fell 6%,Baidu fell 5%,Xpeng Motors fell 4%,Alibaba,Nio and Li Auto fell 3%.","news_type":1,"symbols_score_info":{"LI":0.9,"NIO":0.9,"JD":0.9,"DIDI":0.9,"PDD":0.9,"XPEV":0.9,"BABA":0.9,"BIDU":0.9}},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819137040,"gmtCreate":1630042697380,"gmtModify":1704955073874,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","listText":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","text":"I love fools.com, i go against their suggestions. Itmakes my work easy to filter better stocks. 😂😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/819137040","repostId":"2162090400","repostType":4,"isVote":1,"tweetType":1,"viewCount":670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805653637,"gmtCreate":1627878175529,"gmtModify":1631891947182,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Will enter when I have an opportunity. SEA is over valued at this time.&nbsp;","listText":"Will enter when I have an opportunity. SEA is over valued at this time.&nbsp;","text":"Will enter when I have an opportunity. SEA is over valued at this time.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/805653637","repostId":"2156741169","repostType":4,"isVote":1,"tweetType":1,"viewCount":675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898832316,"gmtCreate":1628483153235,"gmtModify":1631884932724,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features&nbsp;","listText":"Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features&nbsp;","text":"Amazon and Apple are good buy, am not bullish o n FB considering countries legal restrictions and apple security features","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/898832316","repostId":"2157492988","repostType":4,"isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":608507755,"gmtCreate":1638755224231,"gmtModify":1638755224231,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","listText":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","text":"Personal choice: I don’t invest or average anymore on Chinese stocks till political issues are sorted. I can’t take this rollercoaster ride.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608507755","repostId":"1107533977","repostType":4,"repost":{"id":"1107533977","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638754268,"share":"https://www.laohu8.com/m/news/1107533977?lang=zh_CN&edition=full","pubTime":"2021-12-06 09:31","market":"us","language":"en","title":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107533977","media":"Tiger Newspress","summary":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","content":"<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港下跌超过14%，小鹏汽车下跌近9%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLi Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.<blockquote>理想汽车股价在港跌超14%，小鹏汽车跌近9%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 09:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Li&nbsp;Auto&nbsp;shares&nbsp;fell&nbsp;more&nbsp;than&nbsp;14%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;and&nbsp;XPeng&nbsp;fell&nbsp;nearly&nbsp;9%.<img src=\"https://static.tigerbbs.com/f4c63a9e3fe26341f23934616826c6a2\" tg-width=\"747\" tg-height=\"603\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/12cd5c05e050cc41f92f4263ac49921a\" tg-width=\"710\" tg-height=\"606\" width=\"100%\" height=\"auto\"></p><p><blockquote>理想汽车股价在香港下跌超过14%，小鹏汽车下跌近9%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","XPEV":"小鹏汽车","09868":"小鹏汽车-W","02015":"理想汽车-W"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107533977","content_text":"Li Auto shares fell more than 14% in Hong Kong and XPeng fell nearly 9%.","news_type":1,"symbols_score_info":{"09868":0.9,"02015":0.9,"LI":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":3498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":810686066,"gmtCreate":1629971819655,"gmtModify":1631888993359,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"I was thinking of buying, now I will back off 😞","listText":"I was thinking of buying, now I will back off 😞","text":"I was thinking of buying, now I will back off 😞","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810686066","repostId":"1113528238","repostType":4,"isVote":1,"tweetType":1,"viewCount":520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800625791,"gmtCreate":1627299814513,"gmtModify":1631891947230,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Waiting for it to dip, I feel it is a value investmentas well","listText":"Waiting for it to dip, I feel it is a value investmentas well","text":"Waiting for it to dip, I feel it is a value investmentas well","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/800625791","repostId":"2154570449","repostType":4,"isVote":1,"tweetType":1,"viewCount":853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808798343,"gmtCreate":1627609239782,"gmtModify":1631891947193,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Am a beginner, can I enter Amazon now.. guidance please","listText":"Am a beginner, can I enter Amazon now.. guidance please","text":"Am a beginner, can I enter Amazon now.. guidance please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/808798343","repostId":"1105519179","repostType":2,"isVote":1,"tweetType":1,"viewCount":1058,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873415599,"gmtCreate":1636975301716,"gmtModify":1636975301716,"author":{"id":"3582610336531043","authorId":"3582610336531043","name":"NBAl","avatar":"https://static.tigerbbs.com/de8d0324ec977b11182ed837042b62e1","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582610336531043","authorIdStr":"3582610336531043"},"themes":[],"htmlText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","listText":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.&nbsp;","text":"Doesn’t matter, am holding long. She would dump it anytime. I rather believe in the companies fundamentals that I bought rather than the news of cathiewood.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873415599","repostId":"2183046479","repostType":4,"isVote":1,"tweetType":1,"viewCount":3647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}